###begin article-title 0
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 44 49 <span type="species:ncbi:9606">human</span>
d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia
###end article-title 0
###begin p 1
Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
###end p 1
###begin p 2
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 13 14 13 14 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 45 46 45 46 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 104 105 104 105 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 131 132 131 132 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 196 197 196 197 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 276 277 276 277 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 493 494 493 494 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 823 824 823 824 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1162 1163 1162 1163 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1265 1266 1265 1266 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1353 1354 1353 1354 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1448 1449 1448 1449 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1109 1113 <span type="species:ncbi:10116">rats</span>
###xml 1303 1308 <span type="species:ncbi:9606">human</span>
The N-methyl-d-aspartate receptor co-agonist d-serine is synthesized by serine racemase and degraded by d-amino acid oxidase. Both d-serine and its metabolizing enzymes are implicated in N-methyl-d-aspartate receptor hypofunction thought to occur in schizophrenia. We studied d-amino acid oxidase and serine racemase immunohistochemically in several brain regions and compared their immunoreactivity and their mRNA levels in the cerebellum and dorsolateral prefrontal cortex in schizophrenia. d-Amino acid oxidase immunoreactivity was abundant in glia, especially Bergmann glia, of the cerebellum, whereas in prefrontal cortex, hippocampus and substantia nigra, it was predominantly neuronal. Serine racemase was principally glial in all regions examined and demonstrated prominent white matter staining. In schizophrenia, d-amino acid oxidase mRNA was increased in the cerebellum, and as a trend for protein. Serine racemase was increased in schizophrenia in the dorsolateral prefrontal cortex but not in cerebellum, while serine racemase mRNA was unchanged in both regions. Administration of haloperidol to rats did not significantly affect serine racemase or d-amino acid oxidase levels. These findings establish the major cell types wherein serine racemase and d-amino acid oxidase are expressed in human brain and provide some support for aberrant d-serine metabolism in schizophrenia. However, they raise further questions as to the roles of d-amino acid oxidase and serine racemase in both physiological and pathophysiological processes in the brain.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 13 14 13 14 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 141 142 141 142 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 151 152 151 152 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 234 253 234 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Schell <italic>et al.</italic>, 1995</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">1997</xref>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 346 365 346 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b68">Thiels <italic>et al</italic>., 1992</xref>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 367 386 367 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56">Mothet <italic>et al</italic>., 2000</xref>
###xml 388 405 388 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">Ito &amp; Hicks, 2001</xref>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 407 424 407 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b81">Yang <italic>et al</italic>., 2003</xref>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 426 446 426 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">Shleper <italic>et al</italic>., 2005</xref>
The N-methyl-d-aspartate receptor (NMDAR) is activated by binding of the neurotransmitter glutamate and an obligatory co-agonist, glycine or d-serine. d-Serine is proposed as the predominant co-agonist, at least in the telencephalon (Schell et al., 1995, 1997), consistent with evidence that it modulates cortical and hippocampal NMDAR activity (Thiels et al., 1992; Mothet et al., 2000; Ito & Hicks, 2001; Yang et al., 2003; Shleper et al., 2005).
###end p 4
###begin p 5
###xml 75 95 75 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58">Olney &amp; Farber, 1995</xref>
###xml 97 108 97 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Coyle, 1996</xref>
###xml 110 125 110 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">Moghaddam, 2003</xref>
###xml 171 192 171 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">Harrison &amp; Owen, 2003</xref>
###xml 194 221 194 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Harrison &amp; Weinberger, 2005</xref>
###xml 233 234 233 234 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 329 330 329 330 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 384 406 384 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Hashimoto <italic>et al</italic>., 2003</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">2005</xref>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 414 433 414 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b80">Yamada <italic>et al</italic>., 2005</xref>
###xml 467 468 467 468 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 548 553 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 543 560 543 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b69">Tsai <italic>et al</italic>., 1998</xref>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 562 587 562 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Heresco-Levy <italic>et al</italic>., 2005</xref>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
NMDAR hypofunction is considered central to schizophrenia pathophysiology (Olney & Farber, 1995; Coyle, 1996; Moghaddam, 2003), and perhaps to its genetic predisposition (Harrison & Owen, 2003; Harrison & Weinberger, 2005). Impaired d-serine function in patients could contribute to NMDAR hypofunction, as central and peripheral d-serine levels are reduced in schizophrenic patients (Hashimoto et al., 2003, 2005; Yamada et al., 2005). Moreover, co-administration of d-serine or related compounds can ameliorate some symptoms of the disorder (Tsai et al., 1998; Heresco-Levy et al., 2005).
###end p 5
###begin p 6
###xml 8 9 8 9 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 83 84 83 84 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 109 110 109 110 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 225 246 225 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Chumakov <italic>et al</italic>., 2002</xref>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 248 264 248 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">Liu <italic>et al</italic>., 2004</xref>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 266 289 266 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b63">Schumacher <italic>et al</italic>., 2004</xref>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 291 310 291 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Corvin <italic>et al</italic>., 2007</xref>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 312 329 312 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b75">Wood <italic>et al</italic>., 2007</xref>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 339 358 339 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b80">Yamada <italic>et al</italic>., 2005</xref>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 360 376 360 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">Liu <italic>et al</italic>., 2006</xref>
###xml 386 391 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 378 398 378 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b70">Vilella <italic>et al</italic>., 2007</xref>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 495 516 495 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">Chumakov <italic>et al</italic>., 2002</xref>
###xml 518 549 518 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">Detera-Wadleigh &amp; McMahon, 2006</xref>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 551 570 551 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">Corvin <italic>et al</italic>., 2007</xref>
###xml 572 585 572 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">Li &amp; He, 2007</xref>
###xml 591 596 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 587 603 587 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b86">Yue <italic>et al</italic>., 2007</xref>
###xml 622 627 622 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 618 634 618 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">Liu <italic>et al</italic>., 2006</xref>
###xml 641 646 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 636 653 636 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b75">Wood <italic>et al</italic>., 2007</xref>
###xml 726 731 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 719 738 719 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56">Mothet <italic>et al</italic>., 2000</xref>
###xml 802 803 802 803 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 905 910 905 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 898 917 898 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Kapoor <italic>et al</italic>., 2006</xref>
###xml 928 933 928 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 919 940 919 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Bendikov <italic>et al</italic>., 2007</xref>
Altered d-serine in schizophrenia may be explained, in part, by involvement of the d-serine catabolic enzyme d-amino acid oxidase (DAO, also abbreviated to DAAO). DAO has been associated with susceptibility to schizophrenia (Chumakov et al., 2002; Liu et al., 2004; Schumacher et al., 2004; Corvin et al., 2007; Wood et al., 2007; but see Yamada et al., 2005; Liu et al., 2006; Vilella et al., 2007) and in addition, its putative activator, G72 (DAOA), also shows association with the disorder (Chumakov et al., 2002; Detera-Wadleigh & McMahon, 2006; Corvin et al., 2007; Li & He, 2007; Yue et al., 2007; but also see Liu et al., 2006; Wood et al., 2007). DAO has been shown to reduce NMDAR-mediated neurotransmission (Mothet et al., 2000) and thus increased DAO in schizophrenia might contribute, via d-serine decrements, to NMDAR dysfunction. Recent studies provide some support for this notion (Kapoor et al., 2006; Bendikov et al., 2007).
###end p 6
###begin p 7
###xml 34 35 34 35 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 48 49 48 49 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 58 80 58 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Wolosker <italic>et al</italic>., 1999a</xref>
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">b</xref>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 277 297 277 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">Goltsov <italic>et al</italic>., 2006</xref>
###xml 306 311 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 299 318 299 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">Morita <italic>et al</italic>., 2007</xref>
###xml 335 340 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 328 347 328 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b80">Yamada <italic>et al</italic>., 2005</xref>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 349 372 349 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b67">Strohmaier <italic>et al</italic>., 2007</xref>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 440 460 440 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b65">Steffek <italic>et al</italic>., 2006</xref>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 462 483 462 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Bendikov <italic>et al</italic>., 2007</xref>
Serine racemase (SRR) synthesizes d-serine from l-serine (Wolosker et al., 1999a, b), and thus alterations in SRR activity could enhance or counteract the postulated role of DAO in schizophrenia. At present, there is weak evidence that SRR itself may be a susceptibility gene (Goltsov et al., 2006; Morita et al., 2007, but see Yamada et al., 2005; Strohmaier et al., 2007), and evidence that its expression may be altered in the disorder (Steffek et al., 2006; Bendikov et al., 2007).
###end p 7
###begin p 8
###xml 181 188 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 413 418 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 404 425 404 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Katagiri <italic>et al</italic>., 1991</xref>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 427 447 427 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Horiike <italic>et al</italic>., 1994</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 449 468 449 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62">Schell <italic>et al</italic>., 1995</xref>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 470 490 470 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Brannan <italic>et al</italic>., 1996</xref>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 492 510 492 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">Moses <italic>et al</italic>., 1996</xref>
###xml 512 528 512 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b71">Wang &amp; Zhu, 2003</xref>
###xml 537 542 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 530 549 530 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Kapoor <italic>et al</italic>., 2006</xref>
###xml 554 559 554 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 551 566 551 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b77">Wu <italic>et al</italic>., 2006</xref>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 568 588 568 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">Kawazoe <italic>et al</italic>., 2007</xref>
###xml 116 121 <span type="species:ncbi:9606">human</span>
The present study had two objectives. First, to characterize the regional and cellular expression of DAO and SRR in human brain. For these studies, we used immunohistochemistry and in situ hybridization and focused on areas of relevance to schizophrenia and where DAO is reputed to be abundant or important, namely the dorsolateral prefrontal cortex (DPFC), hippocampus, cerebellum and substantia nigra (Katagiri et al., 1991; Horiike et al., 1994; Schell et al., 1995; Brannan et al., 1996; Moses et al., 1996; Wang & Zhu, 2003; Kapoor et al., 2006; Wu et al., 2006; Kawazoe et al., 2007). Our second objective was to extend the current data regarding altered expression of DAO and SRR in schizophrenia. For these studies we used real-time PCR and Western blotting as more robust methods to determine mRNA and protein abundance, respectively, and focused on the DPFC and cerebellum, given the reported preferential localizations of SRR and DAO in these regions.
###end p 8
###begin title 9
Materials and methods
###end title 9
###begin title 10
Subjects studied
###end title 10
###begin p 11
###xml 135 142 135 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 622 627 622 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 613 635 613 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Eastwood <italic>et al</italic>. (2001b</xref>
###xml 329 337 <span type="species:ncbi:9606">patients</span>
Brain tissue was collected at autopsy with consent at two centres, Oxford and London. Demographic details of the subjects are shown in Table 1. Schizophrenia was diagnosed from case notes according to DSM-III-R (American Psychiatric Association, 1987) criteria. Most cases were initially of paranoid or disorganized subtype. All patients had received conventional antipsychotics. Control individuals had no history of psychiatric of neurological illness. Neuropathological assessment of all brains did not identify any neurodegenerative abnormalities other than minor age-related changes. For further details see Eastwood et al. (2001b). The research was approved by the Oxfordshire Psychiatric Research Ethics Committee.
###end p 11
###begin p 12
###xml 37 45 <span type="species:ncbi:9606">patients</span>
Demographic details of schizophrenia patients and control individuals
###end p 12
###begin p 13
Values are means +/- SEM (and ranges). There are no significant demographic differences between diagnostic groups in the Oxford, London or combined series. Tissue was not available from all subjects for every experiment.
###end p 13
###begin title 14
Tissue collection and processing
###end title 14
###begin p 15
Blocks were collected from the DPFC (Brodmann area 9/46), cerebellum, hippocampus and (for DAO only) from midbrain containing the substantia nigra. Blocks from the Oxford series were dissected directly at autopsy and stored at -80 degreesC. Blocks from the London series were dissected from previously snap-frozen coronal brain slices at -20 degreesC and returned to storage at -80 degreesC. Sections from both series were cut at 18 microm, collected on Superfrost Plus slides (BDH Merck, Poole, UK) and stored at -80 degreesC. From some subjects in the Oxford series, formalin-fixed paraffin-wax-embedded blocks were also taken for immunohistochemistry. From these, 10-microm sections were cut and collected on coated slides. All material was coded and experiments carried out blind to diagnosis.
###end p 15
###begin title 16
Generation of antisera to DAO
###end title 16
###begin p 17
###xml 763 764 757 758 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 821 822 815 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 2 8 <span type="species:ncbi:9986">rabbit</span>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
###xml 556 561 <span type="species:ncbi:9606">human</span>
###xml 689 693 <span type="species:ncbi:9913">calf</span>
A rabbit polyclonal antibody against a C-terminal human DAO sequence (peptide H-CGRILEEKKLSRMPPSHL-OH; N-terminal Cys added for coupling) was produced by Cambridge Research Biochemicals (Billingham, UK). Crude antiserum was purified by affinity chromatography on Thiopropyl Sepharose 6B derivatized with the antigen. The concentration of anti-DAO antibody in glycine eluates was 0.77 mg/mL. Specificity to DAO was tested by Western blotting using human tissue lysates (protein medleys, Clontech, VWR International) and recombinant N-terminally flag-tagged human DAO expressed in HEK293 cells. HEK293 cells were cultured in Minimum Essential Medium (MEM, Gibco) supplemented with 10% fetal calf serum and non-essential amino acids (Gibco) at 37 degreesC and 10% CO2. Cells were plated 1 day before transfection at 3.5 x 106 cells per 10-cm plate and transiently transfected with 6 microg plasmid-DNA using Fugene 6 transfection reagent (Roche) according to the manufacturer's instructions. Cells were incubated with transfection mix for 38 h prior to extraction of cell lysates for Western blotting analysis.
###end p 17
###begin title 18
Western blotting
###end title 18
###begin p 19
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 89 111 89 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Eastwood <italic>et al</italic>., 2001b</xref>
###xml 175 176 175 176 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 200 201 200 201 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 225 226 225 226 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 454 455 454 455 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 679 680 676 677 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1113 1115 1107 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sup>
###xml 2169 2171 2150 2152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sup>
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 17 20 <span type="species:ncbi:10116">rat</span>
###xml 1943 1948 <span type="species:ncbi:10090">mouse</span>
###xml 2042 2048 <span type="species:ncbi:9986">rabbit</span>
Frozen human and rat tissue sections were homogenized in suspension buffer as described (Eastwood et al., 2001b). HEK293 cell lysates were extracted in suspension buffer (50 mm Tris-HCl, pH 7.5, 150 mm NaCl, 10% glycerol, 1 mm EDTA, 0.8% Triton X-100) with added 'Complete' protease inhibitors (Roche) and Phosphatase inhibitor cocktail (Sigma). Immediately before electrophoresis samples were mixed 4 : 1 with 5x loading buffer [final concentration 0.1 m Tris-chloride, 2% sodium dodecyl sulphate (SDS), 10% glycerol, 1%beta-mercaptoethanol, 0.02% Bromophenol blue] and boiled for 10 min. Clontech protein medleys were diluted in 1x loading buffer (as above, but containing 50 mm DTT instead of beta-mercaptoethanol) and boiled for 5 min prior to electrophoresis. Equal protein concentrations and a molecular weight marker rainbow ladder (GE Healthcare, Buckinghamshire, UK or Bio-Rad, Hertfordshire, UK) were fractionated in duplicate by electrophoresis on a 12% SDS/polyacrylamide gel and transferred onto a polyvinyl difluoride membrane. Membranes were immersed in blocking buffer (2% non-fat milk, 0.1% Tween20 in phosphate buffered saline (PBS)) for 1 h followed by an overnight incubation at 4 degreesC with primary antibody [SRR 1 : 500; BD Biosciences; DAO (0.25-0.75 microg/mL); anti-flag M2 1 : 15000; Sigma] in the same buffer. For quantitative measurements, membranes were simultaneously incubated with a commercially available antibody to cyclophilin (1 : 100 000; Abcam, Cambridge, UK), which detects a band of 20 kDa to serve as a loading control. For Western blots with Clontech protein medleys, blots were stripped of the primary anti-DAO antibody (Re-Blot Plus Western blot recycling kit, Chemicon, Hampshire, UK) and re-probed with anti-actin as a loading control (1 : 10000; Chemicon). Membranes were washed three times in blocking buffer, incubated for 1 h with HRP-conjugated secondary antibody in blocking buffer (anti-mouse immunoglobulin 1 : 1000, DAKO, Cambridgeshire, UK, for SRR, flag-M2 and beta-actin, and anti-rabbit immunoglobulin 1 : 5000, Chemicon, for DAO and cyclophilin) followed by washing three times in PBS containing 0.1% Tween20. Immunoreactive bands were visualized on X-ray film using the 'ECL Plus' kit (GE Healthcare) on Kodak BioMax X-Omat AR film (Sigma). Bands were analysed by densitometry and optical density values for the target immunoreactive bands normalized to those of the housekeeping gene signals. Specificity for all antibodies in Western blotting was assessed in control experiments where the primary antibody was omitted. For DAO, a preadsorption control with the antigenic peptide was also carried out.
###end p 19
###begin title 20
Immunohistochemistry
###end title 20
###begin p 21
###xml 333 338 <span type="species:ncbi:9796">horse</span>
###xml 340 343 <span type="species:ncbi:9796">SRR</span>
###xml 348 352 <span type="species:ncbi:9925">goat</span>
###xml 354 357 <span type="species:ncbi:9925">DAO</span>
###xml 600 603 <span type="species:ncbi:9796">SRR</span>
###xml 641 644 <span type="species:ncbi:9925">DAO</span>
###xml 757 762 <span type="species:ncbi:9796">horse</span>
###xml 768 773 <span type="species:ncbi:10090">mouse</span>
###xml 775 778 <span type="species:ncbi:9796">SRR</span>
###xml 783 787 <span type="species:ncbi:9925">goat</span>
###xml 793 799 <span type="species:ncbi:9986">rabbit</span>
###xml 801 804 <span type="species:ncbi:9925">DAO</span>
###xml 1242 1245 <span type="species:ncbi:9925">DAO</span>
The paraffin-wax-embedded sections were de-waxed in xylene overnight, rehydrated in graded ethanol, and microwaved in antigen unmasking solution (Vector Laboratories, Peterborough, UK) at 100 degreesC for 10 min. The tissue was pretreated with 3% hydrogen peroxide. Following the blocking of non-specific binding sites in 10% normal horse (SRR) or goat (DAO) serum in PBS-0.3% Triton X-100 (PBS-T), sections were washed in PBS-T and incubated overnight at 4 degreesC with primary antibody. Primary antibody concentrations were titrated in pilot experiments for optimal detection and used as follows: SRR (BD Biosciences, Oxford, UK) 1 : 35; DAO 1.5 microg/mL, except for DPFC (3.75 microg/mL). After a 30-min treatment with 1 : 100 dilution of biotinylated horse anti-mouse (SRR) or goat anti-rabbit (DAO) immunoglobulin (Sigma), the antibody was localized by the avidin-biotin-peroxidase technique using the Vectastain Elite ABC kit (Vector Laboratories). The peroxidase reaction was demonstrated with 3,3'-diaminobenzidine (DAB). Cresyl violet was used as a counterstain for some sections. Specificity for all antibodies in immunohistochemistry experiments was assessed in control experiments where the primary antibody was omitted and for DAO with a preadsorption control.
###end p 21
###begin title 22
###xml 8 36 8 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hybridization histochemistry</italic>
In situ hybridization histochemistry
###end title 22
###begin p 23
###xml 240 247 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 316 321 316 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 309 328 309 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">Burnet <italic>et al</italic>., 1994</xref>
###xml 523 525 523 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 538 539 538 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 673 674 673 674 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 773 774 773 774 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 822 823 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 16 19 <span type="species:ncbi:9925">DAO</span>
###xml 384 387 <span type="species:ncbi:9925">DAO</span>
###xml 893 898 <span type="species:ncbi:9606">human</span>
Amplified human DAO cDNA (400-bp fragment, base-pairs 441-840 of Accession No. NM_001917) was subcloned into pGEM-T Easy Vector (Promega, Southampton, UK) following the manufacturer's recommendations. Protocols for riboprobe production and in situ hybridization histochemistry have been previously described (Burnet et al., 1994). Briefly, riboprobes were produced by linearizing the DAO-pGEM-T construct with appropriate restriction endonucleases and transcribing using either SP6 or T7 promoter sites in the presence of [35S]UTP (1000 Ci/mmol). The probe was diluted with hybridization buffer [75% formamide, 3x standard saline citrate (SSC), 1x Denhardt's solution, 50 mm sodium phosphate buffer, pH 7.4, 10% dextran sulphate, 0.1 mg/mL sheared salmon sperm DNA and 20 mm dithiothreitol] to a final activity of 1.2 x 104 c.p.m./mL. The diluted probe (200 microL) was added to each slide of human tissue sections and covered with a glass coverslip. All slides were incubated overnight at 50 degreesC in lidded Perspex trays lined with filter paper soaked with 3x SSC/75% formamide.
###end p 23
###begin p 24
###xml 299 300 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 432 437 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 423 445 407 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Eastwood <italic>et al</italic>., 2001b</xref>
For post-hybridization washing, slides were first rinsed in 2x SSC, incubated in RNase A (20 microg/mL) for 30 min at room temperature, and immersed in 2x SSC at 55 degreesC for 10 min, 0.5x SSC at 55 degreesC for 60 min and finally 0.5x SSC at room temperature for 10 min. Slides were rinsed in ddH2O, dried and apposed to X-ray film (Kodak) at room temperature, or dipped in photographic emulsion using standard methods (Eastwood et al., 2001b). Emulsion-dipped slides were developed and counterstained with cresyl violet.
###end p 24
###begin title 25
mRNA extraction and real-time PCR
###end title 25
###begin p 26
###xml 7 12 <span type="species:ncbi:9606">human</span>
Frozen human tissue sections (DPFC and cerebellum) were homogenized in TRI reagent (Sigma) according to the manufacturer's instructions. Total RNA concentration was determined spectrophotometrically. Total RNA was treated with RNase-free DNase (Promega) according to the manufacturer's instructions. DNase-treated total RNA (1-2 microg) was reverse transcribed using a high-capacity cDNA archive kit (Applied Biosystems, Warrington, UK) and cDNA stored at -70 degreesC.
###end p 26
###begin p 27
###xml 177 178 177 178 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 219 222 <span type="species:ncbi:9796">SRR</span>
###xml 279 282 <span type="species:ncbi:9925">DAO</span>
###xml 465 468 <span type="species:ncbi:9925">DAO</span>
###xml 470 473 <span type="species:ncbi:9796">SRR</span>
Real-time PCR was performed in an ABI Prism 7000 Sequence Detector system (Applied Biosystems) using a real-time PCR kit for SYBR Green I (Eurogentec, Southampton, UK) and 100 nm of forward and reverse primers (Sigma) (SRR (F) AACCTAGTGATGAGTCCAGAGAAA, (R) CTGGTTGGGATGTACCATGA; DAO (F) CGCAGACGTGATTGTCAACT, (R) GGATGATGTACGGGGAATTG; r18s (F) GTAACCCGTTGAACCCCATT, (R) CCATCCAATCGGTAGTAGCG; GAPDH (F) AAGGTGAAGGTCGGAGTC, (R) GAAGATGGTGATGGGATTTC). The primers for DAO, SRR and the 'housekeeping genes' ribosomal 18 s (r18s) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were designed using Primer 3 software (). Specificity of primers for each transcript was confirmed using a nucleotide-nucleotide alignment search (). Thermal cycling was initiated with incubation at 50 degreesC for 2 min and 95 degreesC for 10 min followed by 40 cycles of 95 degreesC for 15 s, 60 degreesC for 1 min and a melt curve analysis was performed at the end of each PCR experiment. All reactions were run in triplicate. Pilot studies established reaction efficiency and assay linearity with each primer pair and melt curve analysis confirmed specific product formation with each primer pair. RNA samples which had not been reverse transcribed (negative controls) were subjected to PCR in the same assay as cDNA samples.
###end p 27
###begin p 28
Fluorescence emission intensity from SYBR Green I was plotted against Ct (cycle of threshold) values corresponding to the number of PCR cycles. For each sample the Ct value was measured at a given threshold of fluorescence emission intensity corresponding to the exponential phase of the PCR reaction. The abundance of target cDNA in each sample was calculated from a standard curve and normalized to the levels of r18s and GAPDH in the same sample.
###end p 28
###begin title 29
###xml 27 31 <span type="species:ncbi:10116">rats</span>
Antipsychotic treatment in rats
###end title 29
###begin p 30
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 298 314 298 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">Law <italic>et al</italic>., 2004</xref>
###xml 11 30 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
Adult male Sprague-Dawley rats (Harlan-Olac, Bicester, UK) weighing 225-250 g were treated with the conventional antipsychotic haloperidol (1 mg/kg/day; n = 8) or the same volume of saline (n = 8) by intraperitoneal injection once daily for 14 days, killed and brain tissue processed as described (Law et al., 2004). All procedures were carried out in accordance with UK Home Office Guidelines. Protein was extracted from frozen brain sections and used for Western blotting as described.
###end p 30
###begin title 31
Statistical analysis
###end title 31
###begin p 32
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 118 139 118 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">Eastwood <italic>et al</italic>., 2000</xref>
###xml 141 146 141 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b47">2001a</xref>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">b</xref>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z</italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 216 238 216 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">Eastwood <italic>et al</italic>., 2001b</xref>
###xml 586 591 586 591 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">anova</sc>
###xml 690 693 690 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P &lt;</italic>
###xml 753 754 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 856 857 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 827 831 <span type="species:ncbi:10116">rats</span>
Previous studies showed that the detected abundance of some mRNAs and proteins differed between the two brain series (Eastwood et al., 2000, 2001a, b). In case a similar effect was seen here, Z-scores were computed (Eastwood et al., 2001b) to allow data from the series to be combined for analysis. We also inspected data from each series separately (see Results). The effects of potential confounding variables (brain pH, post-mortem interval and age) were explored using correlations partialled for diagnosis. Effects of diagnosis were investigated with one-way analysis of variance (anova) with brain pH, post-mortem interval and age as covariates where the correlation was significant (P < 0.05). For data not normally distributed, the Mann-Whitney U-test was used. To test for an effect of antipsychotic drug treatment in rats, an independent samples t-test was used.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
###xml 14 17 <span type="species:ncbi:9925">DAO</span>
###xml 22 25 <span type="species:ncbi:9796">SRR</span>
Validation of DAO and SRR antibodies
###end title 34
###begin p 35
###xml 382 389 358 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 463 468 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 455 475 431 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">Gavazzi <italic>et al</italic>., 1987</xref>
###xml 486 491 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 477 498 453 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Katagiri <italic>et al</italic>., 1991</xref>
###xml 507 512 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 500 519 476 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">Moreno <italic>et al</italic>., 1999</xref>
###xml 743 750 719 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 833 840 809 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 13 16 <span type="species:ncbi:9925">DAO</span>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 63 66 <span type="species:ncbi:9925">DAO</span>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 193 196 <span type="species:ncbi:9925">DAO</span>
###xml 264 267 <span type="species:ncbi:9925">DAO</span>
###xml 317 320 <span type="species:ncbi:9925">DAO</span>
###xml 450 453 <span type="species:ncbi:9925">DAO</span>
###xml 563 566 <span type="species:ncbi:9925">DAO</span>
###xml 587 590 <span type="species:ncbi:9925">DAO</span>
###xml 658 661 <span type="species:ncbi:9925">DAO</span>
###xml 804 807 <span type="species:ncbi:9925">DAO</span>
A novel anti-DAO antibody, directed against a C-terminal human DAO peptide, was validated by Western blotting using lysates from HEK-293 cells over-expressing an N-terminally flag-tagged human DAO construct, containing a start codon in the flag tag as well as the DAO start codon. The antibody recognized recombinant DAO as a double band at approximately39 and approximately42 kDa (Fig. 1A, lane 1). The lower band, of predicted molecular weight for DAO (Gavazzi et al., 1987; Katagiri et al., 1991; Moreno et al., 1999), probably represents transfected untagged DAO translated from the DAO start codon, as only the higher band, corresponding to flag-tagged DAO (translated from the flag start codon), was detected with an anti-flag antibody (Fig. 1A, lane 3) and HEK-293 cells do not express endogenous DAO (mock-transfected cells; Fig. 1A, lanes 2 and 4).
###end p 35
###begin p 36
###xml 13 16 <span type="species:ncbi:9925">DAO</span>
###xml 21 24 <span type="species:ncbi:9796">SRR</span>
###xml 44 47 <span type="species:ncbi:9925">DAO</span>
###xml 80 83 <span type="species:ncbi:9925">DAO</span>
###xml 131 134 <span type="species:ncbi:9925">DAO</span>
###xml 187 190 <span type="species:ncbi:9925">DAO</span>
###xml 243 246 <span type="species:ncbi:9925">DAO</span>
###xml 287 290 <span type="species:ncbi:9925">DAO</span>
###xml 383 386 <span type="species:ncbi:9925">DAO</span>
###xml 452 455 <span type="species:ncbi:9925">DAO</span>
###xml 467 470 <span type="species:ncbi:9925">DAO</span>
###xml 546 549 <span type="species:ncbi:9925">DAO</span>
###xml 565 570 <span type="species:ncbi:9606">human</span>
###xml 779 782 <span type="species:ncbi:9925">DAO</span>
###xml 976 979 <span type="species:ncbi:9925">DAO</span>
###xml 997 1000 <span type="species:ncbi:9925">DAO</span>
###xml 1045 1048 <span type="species:ncbi:9796">SRR</span>
###xml 1119 1124 <span type="species:ncbi:9606">human</span>
###xml 1148 1151 <span type="species:ncbi:10116">rat</span>
###xml 1172 1175 <span type="species:ncbi:9925">DAO</span>
###xml 1216 1219 <span type="species:ncbi:9796">SRR</span>
Detection of DAO and SRR. (A) Validation of DAO antibody using recombinant flag-DAO expressed in HEK293 cells. Detection with anti-DAO (lanes 1 and 2) and anti-flag (lanes 3 and 4). Flag-DAO is detected as a approximately42-kDa band with anti-DAO (lane 1) and anti-flag (lane 3) in flag-DAO transfected HEK293 cells but not mock transfected cells (lanes 2 and 4). Expressed untagged DAO is detected as a approximately39-kDa band, of predicted size for DAO, with anti-DAO antibody (lane 1 lower band) but not anti-flag (lane 3). (B) Validation of DAO antibody using human tissue samples (Clontech protein medleys); lane 1, cerebellum; lane 2, amygdala; lane 3, hippocampus; lane 4, thalamus; lane 5, spinal cord; lane 6, lung; lane 7, heart; lane 8, kidney. A specific signal for DAO was detected at approximately39 kDa in the cerebellum, spinal cord and kidney. Blots were re-probed with anti-beta-actin as a loading control (lower panel). (C) Representative Western blots of DAO (lanes 1 and 2), DAO pre-adsorption control (lanes 3 and 4), and SRR (lanes 5-6) in protein extracts of post-mortem cerebellar tissue from human (lanes 1, 3 and 5) and rat (lanes 2, 4 and 6). DAO was detected at approximately39 kDa and SRR at approximately38 kDa. Blots were simultaneously probed for cyclophilin as a loading control (lower band), which was detected at approximately20 kDa.
###end p 36
###begin p 37
###xml 378 383 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 369 390 357 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Katagiri <italic>et al</italic>., 1991</xref>
###xml 400 405 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 392 412 380 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Horiike <italic>et al</italic>., 1994</xref>
###xml 415 422 403 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1B</xref>
###xml 517 524 505 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1C</xref>
###xml 620 627 608 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1C</xref>
###xml 34 37 <span type="species:ncbi:9925">DAO</span>
###xml 71 74 <span type="species:ncbi:9925">DAO</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 328 331 <span type="species:ncbi:9925">DAO</span>
###xml 430 433 <span type="species:ncbi:9925">DAO</span>
###xml 484 489 <span type="species:ncbi:9606">human</span>
###xml 494 497 <span type="species:ncbi:10116">rat</span>
###xml 563 566 <span type="species:ncbi:9925">DAO</span>
###xml 644 649 <span type="species:ncbi:9606">human</span>
###xml 678 681 <span type="species:ncbi:9925">DAO</span>
###xml 841 844 <span type="species:ncbi:10116">rat</span>
###xml 861 864 <span type="species:ncbi:9925">DAO</span>
In order to confirm that the anti-DAO antibody could detect endogenous DAO in human tissue samples, human protein medleys from different brain regions and peripheral tissues were analysed by Western blotting. A strong single band at approximately approximately39 kDa was detected in tissues reportedly expressing high levels of DAO (cerebellum, spinal cord and kidney; Katagiri et al., 1991; Horiike et al., 1994) (Fig. 1B). Anti-DAO detected a similar band in our extracts of frozen human and rat cerebellar tissue (Fig. 1C, lanes 1-2), and preadsorption of the DAO antibody with antigenic peptide abolished this band (Fig. 1C, lanes 3-4). In human DPFC extracts, detection of DAO by Western blotting was extremely variable and sometimes absent, despite trying a range of antibody and protein concentrations (data not shown). Similarly, in rat frontal cortex, DAO could not be detected by Western blotting (data not shown).
###end p 37
###begin p 38
###xml 95 100 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 86 108 74 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b74">Wolosker <italic>et al</italic>., 1999b</xref>
###xml 121 126 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 110 133 98 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">De Miranda <italic>et al</italic>., 2000</xref>
###xml 165 173 153 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1C,</xref>
###xml 0 3 <span type="species:ncbi:9796">SRR</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 149 152 <span type="species:ncbi:10116">rat</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 207 210 <span type="species:ncbi:10116">rat</span>
###xml 286 289 <span type="species:ncbi:9796">SRR</span>
SRR was detected as a single band of predicted molecular weight, approximately38 kDa (Wolosker et al., 1999b; De Miranda et al., 2000), in human and rat cerebellum (Fig. 1C, lanes 5-6) and in human DPFC and rat prefrontal cortex (data not shown). Omission of primary antibody abolished SRR immunoreactivity (data not shown).
###end p 38
###begin p 39
###xml 169 182 142 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1B and C</xref>
The housekeeping genes cyclophilin and beta-actin were detected as single bands of predicted molecular weights of approximately20 and approximately43 kDa, respectively (Fig. 1B and C).
###end p 39
###begin p 40
###xml 179 193 179 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figs 2J and 3F</xref>
###xml 53 56 <span type="species:ncbi:9796">SRR</span>
###xml 100 103 <span type="species:ncbi:9925">DAO</span>
In immunohistochemistry experiments, omission of the SRR primary antibody, and preadsorption of the DAO antibody with the antigenic peptide, abolished immunolabelling (see below; Figs 2J and 3F).
###end p 40
###begin p 41
###xml 718 725 718 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 2026 2033 2026 2033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 38 41 <span type="species:ncbi:9925">DAO</span>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 66 69 <span type="species:ncbi:9925">DAO</span>
###xml 206 209 <span type="species:ncbi:9925">DAO</span>
###xml 515 518 <span type="species:ncbi:9925">DAO</span>
###xml 775 778 <span type="species:ncbi:9925">DAO</span>
###xml 875 878 <span type="species:ncbi:9925">DAO</span>
###xml 1054 1057 <span type="species:ncbi:9925">DAO</span>
###xml 1184 1187 <span type="species:ncbi:9925">DAO</span>
###xml 1384 1387 <span type="species:ncbi:9925">DAO</span>
###xml 1690 1693 <span type="species:ncbi:9925">DAO</span>
###xml 1952 1955 <span type="species:ncbi:9925">DAO</span>
###xml 2198 2201 <span type="species:ncbi:9925">DAO</span>
Regional and cellular distribution of DAO in the human brain. (A) DAO immunoreactivity in the DPFC demonstrating an enhancement of labelling in the grey matter (gm) compared with the white matter (wm). (B) DAO immunoreactivity in DPFC grey matter demonstrating immunolabelling of pyramidal neurons (*), throughout their cell bodies, and sometimes granular. Punctate spots of immunolabelling are seen throughout the neuropil (arrows), in addition to the labelling of occasional small round cells (arrowhead). Inset: DAO immunoreactivity in the white matter as punctate spots of fibre labelling and moderate staining of numerous small round cells, often with peri-cellular enhancement (*). (C) Emulsion dipped antisense in situ hybridized DPFC sections showing localization of DAO mRNA to pyramidal cells (arrows). (C') Corresponding image after sense probe hybridization. (D) DAO immunoreactivity in the hippocampus, demonstrating labelling predominantly in neuronal subfields ca1-4 and (in some cases) in the granule cells of the dentate gyrus (dg). (E) DAO immunoreactivity in ca1 pyramidal neurons. (F) Dentate gyrus, showing moderate staining of granule cells (dg). (G) Cerebellar DAO immunoreactivity showing localization predominantly to the Purkinje cell layer (pcl) with moderate immunolabelling in the molecular layer (ml), granule cell layer (gcl) and white matter (wm). (H) DAO immunoreactivity in the cerebellum demonstrating strongly immunopositive putative Bergmann glia (arrows) in the Purkinje cell layer (pcl) with unstained Purkinje cells (*). In the molecular layer (ml) moderate immunolabelling of putative Bergmann glia radial processes (rp) can be seen. (I) Cerebellar DAO immunoreactivity localized to small round cells of similar size in the molecular layer (arrow a), granule cell layer (arrow b) and white matter (arrow c). Often these cells showed peri-cellular enhancement in staining (inset). (J) Pre-adsorption control for DAO immunohistochemistry in the cerebellum. (K) Emulsion dipped antisense in situ hybridized sections demonstrating silver grains clustered over putative Bergmann glia (arrows) but not over Purkinje cells (*) or the granule cell layer (gcl). (L) DAO immunoreactivity in the substantia nigra pars compacta localized to large neurons and to some small round cells, putatively glia (arrows). Cresyl violet-stained sections (inset) demonstrate lipofuscin in neurons (arrow). Scale bars = 1 mm (A), 0.5 mm (D, G), 50 microm (B, C, C', E, F, H-L).
###end p 41
###begin title 42
###xml 36 39 <span type="species:ncbi:9925">DAO</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
Regional and cellular expression of DAO in the human brain
###end title 42
###begin p 43
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
DAO was detected by immunohistochemistry in all regions examined, but the cell types and staining intensity differed between regions.
###end p 43
###begin title 44
DPFC
###end title 44
###begin p 45
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 208 215 208 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 271 290 271 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">Arnold <italic>et al</italic>., 1979</xref>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 292 311 292 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">Moreno <italic>et al</italic>., 1999</xref>
###xml 392 399 392 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
###xml 466 473 466 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
###xml 768 776 768 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B,</xref>
###xml 25 28 <span type="species:ncbi:9925">DAO</span>
###xml 266 269 <span type="species:ncbi:9925">DAO</span>
###xml 613 616 <span type="species:ncbi:9925">DAO</span>
In the DPFC grey matter, DAO immunoreactivity was predominantly neuronal (Fig. 2A), and visible throughout the cytoplasm of pyramidal neuron cell bodies, sometimes granular, and surrounding unstained nuclei (Fig. 2B). Granular immunostaining may reflect peroxisomal DAO (Arnold et al., 1979; Moreno et al., 1999). Punctate spots of immunoreactivity were also visible throughout the neuropil (Fig. 2B). Immunolabelling of small round cells was visible in some cases (Fig. 2B); given their size they may be glia, or, alternatively, interneurons. In DPFC white matter, immunostaining was weak, but moderate punctate DAO immunoreactivity was visible in addition to the labelling of small round cells, sometimes demonstrating a peri-cellular enhancement in their staining (Fig. 2B, inset). Again the exact identity of these cells is unknown, but based on their size, morphology and location, they are putatively identified as glia.
###end p 45
###begin p 46
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 169 184 169 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2C and 2C&#8242;</xref>
###xml 69 72 <span type="species:ncbi:9925">DAO</span>
###xml 207 210 <span type="species:ncbi:9925">DAO</span>
In situ hybridization and emulsion dipping of DPFC sections revealed DAO mRNA signals clustered over pyramidal neurons with minimal labelling of sense control sections (Fig. 2C and 2C'). In the white matter DAO mRNA signals were marginal (data not shown).
###end p 46
###begin title 47
Hippocampus
###end title 47
###begin p 48
###xml 167 174 167 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2D</xref>
###xml 242 249 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2E</xref>
###xml 517 524 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2E</xref>
###xml 670 677 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2F</xref>
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
###xml 379 382 <span type="species:ncbi:9925">DAO</span>
DAO immunoreactivity in the hippocampus was principally localized to the stratum pyramidale of Ammon's horn and in some cases to the dentate gyrus granule cell layer (Fig. 2D). Pyramidal neurons in CA1 displayed moderate to intense staining (Fig. 2E). CA2/CA3 and CA4 regions displayed moderate neuronal labelling but staining appeared less intense than in CA1 (data not shown). DAO immunoreactivity was visible throughout pyramidal cell bodies, sometimes granular or peri-cellular, while the nucleus was unlabelled (Fig. 2E). In the dentate gyrus, immunoreactivity was variable; half the cases studied demonstrated moderate to strong immunoreactivity of granule cells (Fig. 2F), while the remainder demonstrated marginal or no immunostaining (data not shown).
###end p 48
###begin p 49
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 76 79 <span type="species:ncbi:9925">DAO</span>
In situ hybridization and emulsion dipping of hippocampus sections revealed DAO mRNA signals clustered over pyramidal neurons in the CA subfields, while signals in other regions were low (data not shown).
###end p 49
###begin title 50
Cerebellum
###end title 50
###begin p 51
###xml 95 102 95 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2G</xref>
###xml 205 212 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2H</xref>
###xml 262 269 262 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2H</xref>
###xml 426 433 426 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2H</xref>
###xml 523 530 523 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2I</xref>
###xml 697 704 697 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2I</xref>
###xml 850 857 850 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2I</xref>
###xml 1257 1265 1257 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2I,</xref>
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
DAO immunoreactivity in the cerebellum was localized predominantly to the Purkinje cell layer (Fig. 2G), and therein to small round cells, which, given their size and location, are putative Bergmann glia (Fig. 2H). The Purkinje cells themselves were unlabelled (Fig. 2H). Processes traversing the molecular layer were also immunoreactive, some of which appeared to arise from Bergmann glia, putatively their radial processes (Fig. 2H). The molecular layer also demonstrated occasional immunolabelling of small round cells (Fig. 2I). In the granule cell layer, Golgi cells and granule cells were unlabelled, but scattered small round cells, somewhat larger than granule cells, were immunoreactive (Fig. 2I). Cells of the white matter, with a similar shape and size to those labelled in the molecular and granule cell layers, were also immunoreactive (Fig. 2I). While the specific identity of these molecular, granule cell and white matter layer cells is unknown, their size, morphology and location suggest they are glia, although the molecular layer cells could also be basket/stellate cells. At the subcellular level, some moderately stained cells, particularly those in the granule cell layer, demonstrated a peri-cellular enhancement of immunolabelling (Fig. 2I, inset).
###end p 51
###begin p 52
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 189 196 189 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2K</xref>
###xml 264 271 264 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2K</xref>
###xml 75 78 <span type="species:ncbi:9925">DAO</span>
In situ hybridization and emulsion dipping of cerebellar sections revealed DAO mRNA signals primarily clustered over small round cells in the Purkinje cell layer, putatively Bergmann glia (Fig. 2K). There were few silver grains over the Purkinje cells themselves (Fig. 2K).
###end p 52
###begin title 53
Substantia nigra pars compacta
###end title 53
###begin p 54
###xml 164 172 164 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2L,</xref>
###xml 327 334 327 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2L</xref>
###xml 181 184 <span type="species:ncbi:9925">DAO</span>
In midbrain sections, cresyl violet staining revealed large, putatively dopaminergic, neurons containing melanin pigment within the substantia nigra pars compacta (Fig. 2L, inset). DAO immunoreactivity was strong in these neurons, and, in cases with stronger immunostaining, immunolabelling of putative glia was also observed (Fig. 2L).
###end p 54
###begin title 55
###xml 36 39 <span type="species:ncbi:9796">SRR</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
Regional and cellular expression of SRR in the human brain
###end title 55
###begin title 56
DPFC
###end title 56
###begin p 57
###xml 101 108 101 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3A</xref>
###xml 225 232 225 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3B</xref>
###xml 409 416 409 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3C</xref>
###xml 514 521 514 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3C</xref>
###xml 0 3 <span type="species:ncbi:9796">SRR</span>
SRR immunolabelling in the DPFC was more abundant in the white matter compared with the grey matter (Fig. 3A). In the grey matter, immunolabelled small round cells were observed amongst unlabelled cortical pyramidal neurons (Fig. 3B). In the white matter, immunolabelling of similar small round cells, more prevalent than those in the grey matter, was observed in addition to punctate white matter labelling (Fig. 3C). These cells frequently demonstrated a punctate or peri-cellular enhancement in immunostaining (Fig. 3C). Based on their size, location and morphology they are putatively identified as glia.
###end p 57
###begin p 58
###xml 38 41 <span type="species:ncbi:9796">SRR</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 178 181 <span type="species:ncbi:9796">SRR</span>
###xml 366 369 <span type="species:ncbi:9796">SRR</span>
###xml 506 509 <span type="species:ncbi:9796">SRR</span>
###xml 564 567 <span type="species:ncbi:9796">SRR</span>
###xml 711 714 <span type="species:ncbi:9796">SRR</span>
Regional and cellular distribution of SRR immunoreactivity in the human brain. (A) DPFC, demonstrating an enhancement of staining in white matter (wm) over grey matter (gm). (B) SRR immunoreactivity with cresyl violet counterstaining in DPFC grey matter, demonstrating immunolabelling of putative glia (arrows) amongst immunonegative pyramidal neurons (purple). (C) SRR immunoreactivity in the DPFC white matter localized to putative glia and as punctate white matter labelling. Inset: high-power image of SRR immunoreactivity in the hippocampal white matter. (D) SRR immunoreactivity in the cerebellum in the white matter (wm), granule cell layer (gcl), Purkinje cell layer (pcl) and molecular layer (ml). (E) SRR immunoreactivity in the cerebellum localized to Bergmann glia of the Purkinje cell layer (arrows a) and their radial processes (rp) in the molecular layer, putative glia of the granule cell layer (arrows b) and putative glia of the molecular layer (arrows c). Purkinje cells were occasionally moderately immunolabelled (inset). (F) Control section after omission of primary antibody. Scale bars = 1 mm (A), 0.5 mm (B), 50 microm (C-F).
###end p 58
###begin title 59
Hippocampus
###end title 59
###begin p 60
###xml 212 220 212 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3C,</xref>
###xml 21 24 <span type="species:ncbi:9796">SRR</span>
Similar to the DPFC, SRR immunoreactivity in the hippocampus was predominantly localized to the white matter, including the alveus, and concentrated over small round cells in addition to punctate immunostaining (Fig. 3C, inset).
###end p 60
###begin title 61
Cerebellum
###end title 61
###begin p 62
###xml 63 70 63 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3D</xref>
###xml 181 188 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3E</xref>
###xml 320 328 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3E,</xref>
###xml 538 545 538 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3E</xref>
###xml 675 682 675 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3E</xref>
###xml 0 3 <span type="species:ncbi:9796">SRR</span>
SRR immunoreactivity in the cerebellum was seen in all layers (Fig. 3D). In the Purkinje cell layer, small round cells situated between Purkinje cells were strongly immunolabelled (Fig. 3E). Their size and location suggest they are putative Bergmann glia. The Purkinje cells were occasionally moderately immunolabelled (Fig. 3E, inset). In the molecular layer, there was moderate immunolabelling of putative Bergmann glia radial processes; additionally, small round cells, potentially basket/stellate or glial cells, were immunolabelled (Fig. 3E). Throughout the granule cell layer, scattered strongly immunopositive cells, slightly larger than granule cells, were observed (Fig. 3E). No cells with an appearance suggestive of Golgi cells were labelled. In the white matter, there was abundant and strong immunostaining of small round cells (data not shown). The immunolabelled cell types in these layers were observed to have a peri-cellular enhancement in immunolabelling (data not shown) and are presumed to be glia. The strong immunoreactivity of the cerebellar white matter also arose from punctate immunostaining (data not shown).
###end p 62
###begin title 63
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
DAO expression in schizophrenia
###end title 63
###begin p 64
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P =</italic>
###xml 269 270 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 270 274 270 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,26</sub>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 296 303 296 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4A</xref>
###xml 428 429 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 429 433 429 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,28</sub>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 454 467 454 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4B and H</xref>
###xml 11 14 <span type="species:ncbi:9925">DAO</span>
###xml 153 156 <span type="species:ncbi:9925">DAO</span>
###xml 179 187 <span type="species:ncbi:9606">patients</span>
###xml 337 340 <span type="species:ncbi:9925">DAO</span>
Cerebellar DAO mRNA levels normalized to r18s correlated with brain pH (P = 0.048). No other effects of brain pH, age or post-mortem interval were seen. DAO mRNA was increased in patients with schizophrenia compared with control individuals whether normalized to r18s (F1,26 = 10.01, P = 0.004) (Fig. 4A) or GAPDH mRNA (data not shown). DAO immunoreactivity in the cerebellum showed a trend to being increased in schizophrenia (F1,28 = 3.79, P = 0.062) (Fig. 4B and H).
###end p 64
###begin p 65
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 645 646 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
###xml 8 11 <span type="species:ncbi:9796">SRR</span>
###xml 68 71 <span type="species:ncbi:9925">DAO</span>
###xml 157 160 <span type="species:ncbi:9925">DAO</span>
###xml 259 262 <span type="species:ncbi:9925">DAO</span>
###xml 330 333 <span type="species:ncbi:9796">SRR</span>
###xml 406 409 <span type="species:ncbi:9796">SRR</span>
###xml 508 511 <span type="species:ncbi:9796">SRR</span>
###xml 578 581 <span type="species:ncbi:9796">SRR</span>
###xml 692 695 <span type="species:ncbi:9925">DAO</span>
###xml 718 721 <span type="species:ncbi:9796">SRR</span>
###xml 751 759 <span type="species:ncbi:9606">patients</span>
DAO and SRR expression schizophrenia. (A) Real-time PCR analysis of DAO mRNA normalized to r18s in the cerebellum. **P < 0.005. (B) Western blot analysis of DAO immunoreactivity normalized to cyclophilin (Cyc) in the cerebellum. (C) Real-time PCR analysis of DAO mRNA normalized to r18s in the DPFC. (D) Real-time PCR analysis of SRR mRNA normalized to r18s in the cerebellum. (E) Western blot analysis of SRR immunoreactivity normalized to cyclophilin (Cyc) in the cerebellum. (F) Real-time PCR analysis of SRR mRNA normalized to r18s in the DPFC. (G) Western blot analysis of SRR immunoreactivity normalized to cyclophilin (Cyc) in the DPFC. *P < 0.05. (H) Representative Western blots for DAO in the cerebellum and SRR in the DPFC (upper bands) of patients with schizophrenia (S) and control subjects (C). The lower band shows the loading control cyclophilin.
###end p 65
###begin p 66
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 105 112 105 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4C</xref>
###xml 13 16 <span type="species:ncbi:9925">DAO</span>
###xml 121 124 <span type="species:ncbi:9925">DAO</span>
###xml 189 192 <span type="species:ncbi:9925">DAO</span>
###xml 271 274 <span type="species:ncbi:9925">DAO</span>
In the DPFC, DAO mRNA normalized to r18s was unchanged in schizophrenia (Mann-Whitney U-test, P = 0.33) (Fig. 4C) as was DAO mRNA normalized to GAPDH (data not shown). In the DPFC, because DAO immunoreactivity was extremely variable and most subjects expressed levels of DAO protein undetectable by Western blotting, no quantification was attempted.
###end p 66
###begin p 67
###xml 205 212 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 27 30 <span type="species:ncbi:9925">DAO</span>
The direction of change in DAO mRNA and protein in the cerebellum in schizophrenia was consistent between the two brain series, but the increase in schizophrenia appeared more marked in the London series (Table 2).
###end p 67
###begin p 68
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
###xml 8 11 <span type="species:ncbi:9796">SRR</span>
DAO and SRR expression in the DPFC and CB in schizophrenia divided by origin of tissue
###end p 68
###begin p 69
Values are means +/- SEM. mRNA normalized to r18s; protein normalized to cyclophilin. n.d., not determined.
###end p 69
###begin title 70
###xml 0 3 <span type="species:ncbi:9796">SRR</span>
SRR expression in schizophrenia
###end title 70
###begin p 71
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 189 193 189 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,27</sub>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 213 220 213 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4D</xref>
###xml 330 331 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 331 335 331 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,30</sub>
###xml 344 345 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 355 362 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4E</xref>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 447 451 447 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,25</sub>
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 472 479 472 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4F</xref>
###xml 634 635 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 642 643 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 654 667 654 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4G and H</xref>
###xml 735 742 735 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 65 68 <span type="species:ncbi:9796">SRR</span>
###xml 119 122 <span type="species:ncbi:9796">SRR</span>
###xml 254 257 <span type="species:ncbi:9796">SRR</span>
###xml 378 381 <span type="species:ncbi:9796">SRR</span>
###xml 513 516 <span type="species:ncbi:9796">SRR</span>
###xml 577 585 <span type="species:ncbi:9606">patients</span>
No effects of age, brain pH or post-mortem interval were seen on SRR mRNA and protein measurements. In the cerebellum, SRR mRNA was unchanged in schizophrenia, whether normalized to r18s (F1,27 = 1.05, P = 0.32) (Fig. 4D) or GAPDH mRNA (data not shown). SRR immunoreactivity in the cerebellum was also unchanged in schizophrenia (F1,30 = 0.22, P = 0.64) (Fig. 4E). In the DPFC, SRR mRNA was unchanged in schizophrenia whether normalized to r18s (F1,25 = 0.002, P = 0.96) (Fig. 4F) or GAPDH mRNA (data not shown). SRR immunoreactivity in the DPFC was increased in schizophrenic patients compared with control individuals (Mann-Whitney U-test, P = 0.027) (Fig. 4G and H). This effect was consistent between the Oxford and London series (Table 2).
###end p 71
###begin title 72
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
###xml 8 11 <span type="species:ncbi:9796">SRR</span>
###xml 27 30 <span type="species:ncbi:10116">rat</span>
DAO and SRR protein in the rat brain following haloperidol administration
###end title 72
###begin p 73
###xml 143 144 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 144 148 138 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(14)</sub>
###xml 159 160 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 441 442 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 442 446 432 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(13)</sub>
###xml 457 458 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 540 541 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 541 545 527 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(14)</sub>
###xml 556 557 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
###xml 29 32 <span type="species:ncbi:10116">rat</span>
###xml 247 250 <span type="species:ncbi:9925">DAO</span>
###xml 320 323 <span type="species:ncbi:9796">SRR</span>
DAO immunoreactivity, in the rat cerebellum was unaffected by haloperidol (saline = 1.27 +/- 0.14 (mean +/- SEM), haloperidol = 1.58 +/- 0.35, t(14) = -0.817, P = 0.428). Values were normalized to cyclophilin immunoreactivity. We could not detect DAO immunoreactivity in the frontal cortex. Haloperidol had no effect on SRR immunoreactivity, normalized to cyclophilin, in the cerebellum (saline = 1.56 +/- 0.15, haloperidol = 1.60 +/- 0.16, t(13) = -0.169, P = 0.869) or frontal cortex (saline = 0.83 +/- 0.04, haloperidol = 0.84 +/- 0.06, t(14) = -0.147, P = 0.885).
###end p 73
###begin title 74
Discussion
###end title 74
###begin p 75
###xml 152 153 152 153 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 533 540 533 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 922 923 922 923 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 124 127 <span type="species:ncbi:9925">DAO</span>
###xml 144 147 <span type="species:ncbi:9796">SRR</span>
###xml 432 435 <span type="species:ncbi:9925">DAO</span>
###xml 440 443 <span type="species:ncbi:9796">SRR</span>
###xml 474 479 <span type="species:ncbi:9606">human</span>
###xml 543 546 <span type="species:ncbi:9925">DAO</span>
###xml 664 667 <span type="species:ncbi:9796">SRR</span>
###xml 769 772 <span type="species:ncbi:9925">DAO</span>
###xml 815 818 <span type="species:ncbi:9796">SRR</span>
###xml 963 966 <span type="species:ncbi:9925">DAO</span>
###xml 971 974 <span type="species:ncbi:9796">SRR</span>
This study investigated the regional and cellular expression in human brain of the enzymes responsible for the degradation (DAO) and synthesis (SRR) of d-serine. It also examined whether the expression of these enzymes was altered in the DPFC or cerebellum in schizophrenia, a disorder in which both enzymes have been implicated as part of a broader abnormality in NMDA receptor-mediated signalling. Our main findings are that: (1) DAO and SRR are expressed widely in adult human brain, in discrete but overlapping cell populations (Table 3). DAO localized to glia in the cerebellum, but in the cerebral cortex was predominantly neuronal. In all regions examined, SRR immnuoreactivity was principally glial, and was more abundant in white matter. (2) In schizophrenia, DAO mRNA was increased in the cerebellum, and SRR increased in the DPFC. These findings have implications for our understanding of the cellular basis of d-serine metabolism and for the roles of DAO and SRR in the normal brain, as well as for their involvement in schizophrenia.
###end p 75
###begin p 76
###xml 20 23 <span type="species:ncbi:9925">DAO</span>
###xml 28 31 <span type="species:ncbi:9796">SRR</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Cellular profile of DAO and SRR immunoreactivity in the human brain
###end p 76
###begin p 77
Immunoreactivity: 0, absent; +/-, weak and variable; +, weak; ++, moderate; +++, strong; n.d., not determined.
###end p 77
###begin p 78
Stellate/basket or glia.
###end p 78
###begin title 79
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
###xml 18 23 <span type="species:ncbi:9606">human</span>
DAO expression in human brain
###end title 79
###begin p 80
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 146 165 146 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Kapoor <italic>et al</italic>., 2006</xref>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 190 211 190 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Katagiri <italic>et al</italic>., 1991</xref>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 213 233 213 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Horiike <italic>et al</italic>., 1994</xref>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 235 254 235 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62">Schell <italic>et al</italic>., 1995</xref>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 256 275 256 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">Moreno <italic>et al</italic>., 1999</xref>
###xml 277 293 277 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b71">Wang &amp; Zhu, 2003</xref>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 295 318 295 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b85">Yoshikawa <italic>et al</italic>., 2004b</xref>
###xml 422 429 422 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2H</xref>
###xml 581 588 581 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2I</xref>
###xml 666 671 666 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 659 678 659 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">Moreno <italic>et al</italic>., 1999</xref>
###xml 707 712 707 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 699 719 699 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">Horiike <italic>et al</italic>., 1987</xref>
###xml 755 760 755 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 748 767 748 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">Moreno <italic>et al</italic>. (1999</xref>
###xml 998 1003 998 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 987 1010 987 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59">Pollegioni <italic>et al</italic>., 2007</xref>
###xml 1095 1100 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1088 1107 1088 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">Moreno <italic>et al</italic>. (1999</xref>
###xml 1161 1162 1161 1162 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1190 1195 1190 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1182 1202 1182 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b64">Shleper <italic>et al</italic>., 2005</xref>
###xml 1278 1283 1278 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1273 1290 1273 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b87">Zaar <italic>et al</italic>., 2002</xref>
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 332 335 <span type="species:ncbi:9925">DAO</span>
###xml 737 740 <span type="species:ncbi:10116">rat</span>
###xml 783 786 <span type="species:ncbi:9925">DAO</span>
###xml 865 870 <span type="species:ncbi:9606">human</span>
###xml 926 929 <span type="species:ncbi:9925">DAO</span>
###xml 974 977 <span type="species:ncbi:9925">DAO</span>
###xml 1268 1271 <span type="species:ncbi:10116">rat</span>
DAO immunoreactivity and mRNA were robustly detected in the cerebellum, in keeping with previous studies of its expression and activity in human (Kapoor et al., 2006) and rodent cerebellum (Katagiri et al., 1991; Horiike et al., 1994; Schell et al., 1995; Moreno et al., 1999; Wang & Zhu, 2003; Yoshikawa et al., 2004b). Cerebellar DAO expression, both mRNA and immunoreactivity, was primarily localized to Bergmann glia (Fig. 2H). Immunoreactivity also localized to other small round cells scattered in the molecular, granule cell and white matter layers that we assume are glia (Fig. 2I). These observations are consistent with previous immunocytochemical (Moreno et al., 1999) and histochemical (Horiike et al., 1987) findings in the rat brain. Moreno et al. (1999) also reported DAO immunoreactivity in Golgi and Purkinje cells, which we did not observe in the human cerebellum. This may be due to a species difference in DAO expression, as is seen for other aspects of DAO biology (Pollegioni et al., 2007). Alternatively, the discrepancy may be attributable to the antibody used by Moreno et al. (1999), which subsequent data suggest may cross-react with d-aspartate oxidase (Shleper et al., 2005), itself abundantly expressed in Golgi and Purkinje cells of the rat (Zaar et al., 2002).
###end p 80
###begin p 81
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 346 365 346 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">Moreno <italic>et al</italic>. (1999</xref>
###xml 815 822 815 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1364 1369 1364 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1357 1376 1357 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Kapoor <italic>et al</italic>., 2006</xref>
###xml 1409 1414 1409 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1400 1421 1400 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Bendikov <italic>et al</italic>. (2007</xref>
###xml 24 27 <span type="species:ncbi:9925">DAO</span>
###xml 88 91 <span type="species:ncbi:9925">DAO</span>
###xml 156 161 <span type="species:ncbi:9606">human</span>
###xml 333 336 <span type="species:ncbi:10116">rat</span>
###xml 505 508 <span type="species:ncbi:9925">DAO</span>
###xml 679 682 <span type="species:ncbi:9925">DAO</span>
###xml 947 950 <span type="species:ncbi:9925">DAO</span>
###xml 1221 1224 <span type="species:ncbi:9925">DAO</span>
###xml 1308 1311 <span type="species:ncbi:9925">DAO</span>
###xml 1443 1446 <span type="species:ncbi:9925">DAO</span>
###xml 1474 1479 <span type="species:ncbi:9606">human</span>
###xml 1543 1546 <span type="species:ncbi:9925">DAO</span>
###xml 1708 1711 <span type="species:ncbi:9925">DAO</span>
The situation regarding DAO in the forebrain has been less clear. Our data confirm that DAO is unequivocally expressed, both as mRNA and as protein, in the human cerebral cortex (DPFC and hippocampus), and also show that this is mainly neuronal with a small glial contribution, consistent with the immunocytochemical findings of the rat study by Moreno et al. (1999), but unlike the situation in cerebellum. These findings raise three issues worthy of mention. First, our antibody did not reliably detect DAO protein by Western blotting in DPFC (or in hippocampus), even though it did in cerebellum, but worked reliably for immunohistochemistry in all areas. Its specificity for DAO is not questioned by this failure, given the experimental controls and corroboration of the immunohistochemical data in DPFC by our in situ hybridization findings, but it does require explanation. Most likely, there is a regional difference in the antigenicity of DAO, possibly consequent to differences in post-translational modification or conformation, which is differentially affected by Western blotting and immunohistochemical protocols. Whether this is related to the fact that cerebellum and cerebral cortex predominantly express DAO in different cell types (glia vs. neurons), or the fact that cerebellum contains a DAO transcript variant not detectable in cortex (Kapoor et al., 2006), is unknown. Of note, Bendikov et al. (2007) did robustly detect DAO by Western blotting in the human parietal cortex, using an antibody raised against purified hog DAO, whereas ours was generated against a specific peptide sequence. Potentially, their antibody may have been less susceptible to any inter-regional differences in DAO sequence, conformation or structure.
###end p 81
###begin p 82
###xml 248 249 248 249 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 354 355 354 355 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 415 434 415 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">Helboe <italic>et al</italic>., 2003</xref>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 436 455 436 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">Matsuo <italic>et al</italic>., 2004</xref>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 457 476 457 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60">Rutter <italic>et al</italic>., 2007</xref>
###xml 518 525 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 570 571 570 571 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 51 54 <span type="species:ncbi:9925">DAO</span>
###xml 513 516 <span type="species:ncbi:9796">SRR</span>
The second issue relates to the fact that cortical DAO immunoreactivity was mainly neuronal, whereas it was largely, if not exclusively, glial in the cerebellum. The basis for, and significance of this is unclear. In the DPFC, it implies that much d-serine catabolism is neuronal rather than glial, consistent with the recent observations that the major d-serine transporter, Asc-1, is also predominantly neuronal (Helboe et al., 2003; Matsuo et al., 2004; Rutter et al., 2007). Together with the localization of SRR (Table 3), the findings suggest that, in the cortex, d-serine is synthesized mainly in glia, but degraded in neurons.
###end p 82
###begin p 83
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 120 141 120 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">Katagiri <italic>et al</italic>., 1991</xref>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 143 163 143 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">Horiike <italic>et al</italic>., 1994</xref>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 165 184 165 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62">Schell <italic>et al</italic>., 1995</xref>
###xml 186 202 186 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b71">Wang &amp; Zhu, 2003</xref>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 204 223 204 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Kapoor <italic>et al</italic>., 2006</xref>
###xml 449 450 449 450 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 615 616 615 616 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 41 44 <span type="species:ncbi:9925">DAO</span>
###xml 80 83 <span type="species:ncbi:9925">DAO</span>
###xml 259 262 <span type="species:ncbi:9925">DAO</span>
###xml 418 421 <span type="species:ncbi:9925">DAO</span>
The third question concerns why cortical DAO expression is robust, but cortical DAO activity is virtually undetectable (Katagiri et al., 1991; Horiike et al., 1994; Schell et al., 1995; Wang & Zhu, 2003; Kapoor et al., 2006). One possibility is that cortical DAO is inactive, perhaps a remnant from an earlier, developmental function, although its robust prolonged expression argues against this. Or, perhaps cortical DAO has a substrate other than d-serine, and catalyses a reaction not detected by the commonly used functional assay. However, if this were the case, it would raise the alternative question of how d-serine is degraded in the cortex.
###end p 83
###begin p 84
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 147 166 147 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">Moreno <italic>et al</italic>., 1999</xref>
###xml 255 256 255 256 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 336 337 336 337 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 343 344 343 344 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 424 444 424 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">Brannan <italic>et al</italic>., 1996</xref>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 446 464 446 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">Moses <italic>et al</italic>., 1996</xref>
###xml 469 474 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 466 481 466 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b77">Wu <italic>et al</italic>., 2006</xref>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 483 503 483 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">Kawazoe <italic>et al</italic>., 2007</xref>
###xml 542 543 542 543 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 558 559 558 559 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 857 862 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 848 869 848 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">Laruelle <italic>et al</italic>., 2003</xref>
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
###xml 142 145 <span type="species:ncbi:10116">rat</span>
###xml 239 242 <span type="species:ncbi:9925">DAO</span>
###xml 668 671 <span type="species:ncbi:9925">DAO</span>
DAO immunoreactivity was strong in putative dopaminergic neurons of the substantia nigra pars compacta, consistent with an observation in the rat (Moreno et al., 1999). This finding is of clinical significance given the demonstration that DAO can oxidize d-DOPA in an alternative pathway for dopamine synthesis, and the suggestion that d- and l-DOPA may be combined therapeutically for the treatment of Parkinson's disease (Brannan et al., 1996; Moses et al., 1996; Wu et al., 2006; Kawazoe et al., 2007). However, the presence of endogenous d-DOPA or other d-isomers of catecholamine precursors in mammals is, to our knowledge, unknown. Nevertheless, the presence of DAO in these neurons suggests that it may play a role in dopaminergic function and, speculatively, the involvement of dopamine or dopamine-glutamate interactions in schizophrenia (Laruelle et al., 2003).
###end p 84
###begin title 85
###xml 0 3 <span type="species:ncbi:9796">SRR</span>
###xml 18 23 <span type="species:ncbi:9606">human</span>
SRR expression in human brain
###end title 85
###begin p 86
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 101 123 101 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b73">Wolosker <italic>et al</italic>., 1999a</xref>
###xml 125 141 125 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b71">Wang &amp; Zhu, 2003</xref>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 143 166 143 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b83">Yoshikawa <italic>et al</italic>., 2004a</xref>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 168 195 168 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Kartvelishvily <italic>et al</italic>., 2006</xref>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 207 223 207 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b78">Xia <italic>et al</italic>., 2004</xref>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 236 256 236 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b65">Steffek <italic>et al</italic>., 2006</xref>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 258 279 258 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Bendikov <italic>et al</italic>., 2007</xref>
###xml 386 399 386 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3B and C</xref>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 531 553 531 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b73">Wolosker <italic>et al</italic>., 1999a</xref>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 555 571 555 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b78">Xia <italic>et al</italic>., 2004</xref>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 573 600 573 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Kartvelishvily <italic>et al</italic>., 2006</xref>
###xml 645 662 645 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b76">Wu &amp; Barger, 2004</xref>
###xml 956 961 956 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 947 969 947 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b73">Wolosker <italic>et al</italic>. (1999a</xref>
###xml 1038 1039 1038 1039 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1055 1060 1055 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1048 1067 1048 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57">Nagata <italic>et al</italic>., 1994</xref>
###xml 1076 1081 1076 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1069 1088 1069 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Schell <italic>et al</italic>., 1995</xref>
###xml 1090 1094 1090 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">1997</xref>
###xml 1129 1130 1129 1130 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1183 1188 1183 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1168 1195 1168 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Kartvelishvily <italic>et al</italic>., 2006</xref>
###xml 1206 1211 1206 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1197 1218 1197 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b72">Williams <italic>et al</italic>., 2006</xref>
###xml 1224 1225 1224 1225 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1344 1349 1344 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1334 1356 1334 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">Kumashiro <italic>et al</italic>., 1995</xref>
###xml 0 3 <span type="species:ncbi:9796">SRR</span>
###xml 229 234 <span type="species:ncbi:9606">human</span>
###xml 304 307 <span type="species:ncbi:9796">SRR</span>
###xml 429 432 <span type="species:ncbi:9796">SRR</span>
###xml 700 703 <span type="species:ncbi:9796">SRR</span>
###xml 856 859 <span type="species:ncbi:9796">SRR</span>
###xml 989 992 <span type="species:ncbi:9796">SRR</span>
###xml 1271 1276 <span type="species:ncbi:9606">human</span>
SRR expression was detected in the DPFC and hippocampus, consistent with previous studies in rodent (Wolosker et al., 1999a; Wang & Zhu, 2003; Yoshikawa et al., 2004a; Kartvelishvily et al., 2006), primate (Xia et al., 2004) and human (Steffek et al., 2006; Bendikov et al., 2007). Within these regions, SRR immunoreactivity was localized to glia of both the grey and the white matter (Fig. 3B and C). Previous reports show that SRR immunolabelled glia are astroctyes, based on colocalization with glial fibrillary acidic protein (Wolosker et al., 1999a; Xia et al., 2004; Kartvelishvily et al., 2006). However, we cannot rule out a microglial (Wu & Barger, 2004) or oligodendrocytic contribution to SRR expression, as a detailed analysis of glial subtype was beyond the scope of this study. Whilst our findings are consistent with a glial localization of SRR, the greater white than grey matter staining in DPFC (and hippocampus) is at odds with Wolosker et al. (1999a), who suggest that SRR is enriched in grey matter astrocytes, as is d-serine (Nagata et al., 1994; Schell et al., 1995, 1997). However, others report abundant d-serine staining in the white matter (Kartvelishvily et al., 2006; Williams et al., 2006) and d-serine concentrations in the white matter of human brain are equal to or greater than those in grey matter (Kumashiro et al., 1995).
###end p 86
###begin p 87
###xml 135 151 135 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b71">Wang &amp; Zhu (2003</xref>
###xml 287 288 287 288 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 297 316 297 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57">Nagata <italic>et al</italic>., 1994</xref>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 318 344 318 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b67 b68">Hashimoto <italic>et al</italic>., 1995a, b</xref>
###xml 353 358 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 346 365 346 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Schell <italic>et al</italic>., 1995</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">1997</xref>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 373 392 373 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">Hamase <italic>et al</italic>., 1997</xref>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 394 415 394 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">Morikawa <italic>et al</italic>., 2001</xref>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 417 436 417 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b82">Yasuda <italic>et al</italic>., 2001</xref>
###xml 438 454 438 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b71">Wang &amp; Zhu, 2003</xref>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 513 536 513 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b83">Yoshikawa <italic>et al</italic>., 2004a</xref>
###xml 542 543 542 543 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 569 590 569 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b72">Williams <italic>et al</italic>., 2006</xref>
###xml 675 676 675 676 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 705 706 705 706 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 722 737 722 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Hashimoto, 2002</xref>
###xml 1008 1009 1008 1009 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1148 1149 1148 1149 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 1191 1206 1191 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">Hashimoto (2002</xref>
###xml 1318 1319 1318 1319 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1335 1340 1335 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1328 1347 1328 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Foltyn <italic>et al</italic>., 2005</xref>
###xml 1373 1374 1373 1374 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1464 1465 1464 1465 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1508 1513 1508 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1499 1520 1499 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">Morikawa <italic>et al</italic>., 2001</xref>
###xml 1588 1589 1588 1589 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1627 1628 1627 1628 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1717 1722 1717 1722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1708 1729 1708 1729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b72">Williams <italic>et al</italic>., 2006</xref>
###xml 14 17 <span type="species:ncbi:9796">SRR</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 61 64 <span type="species:ncbi:10116">rat</span>
###xml 108 111 <span type="species:ncbi:9796">SRR</span>
###xml 170 173 <span type="species:ncbi:9796">SRR</span>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
###xml 503 506 <span type="species:ncbi:9796">SRR</span>
###xml 754 757 <span type="species:ncbi:9796">SRR</span>
###xml 881 884 <span type="species:ncbi:9796">SRR</span>
###xml 894 899 <span type="species:ncbi:9606">human</span>
###xml 1066 1069 <span type="species:ncbi:9796">SRR</span>
###xml 1266 1269 <span type="species:ncbi:9796">SRR</span>
###xml 1476 1479 <span type="species:ncbi:9925">DAO</span>
###xml 1754 1757 <span type="species:ncbi:9796">SRR</span>
We identified SRR mRNA and immunoreactivity in the human and rat cerebellum. Previous studies of cerebellar SRR have been conflicting. Wang & Zhu (2003) could not detect SRR by immunoblotting in adult mouse cerebellum, in line with reported low or negligible levels of rodent cerebellar d-serine (Nagata et al., 1994; Hashimoto et al., 1995a, b; Schell et al., 1995, 1997; Hamase et al., 1997; Morikawa et al., 2001; Yasuda et al., 2001; Wang & Zhu, 2003). However, other studies have robustly detected SRR mRNA (Yoshikawa et al., 2004a) and d-serine immunoreactivity (Williams et al., 2006) in adult rodent cerebellum. Furthermore, intracerebroventricular administration of l-serine increases cerebellar d-serine levels (Hashimoto, 2002), implying that SRR is present (and active) in the adult cerebellum. Our data indicate that there is a significant and sustained expression of SRR in adult human cerebellum. It remains to be explained therefore why the majority of studies cited above suggest cerebellar d-serine levels are negligible. Possibilities include the SRR being inactive, or that it is catalysing conversion of a substrate other than l-serine, although the implications of the Hashimoto (2002) study would not support this. Another possibility is that SRR is acting as an eliminase enzyme, breaking down d-serine (Foltyn et al., 2005). Alternatively, the low d-serine levels seen in cerebellar homogenates may be misleading. The rapid degradation of d-serine by DAO in the cerebellum (Morikawa et al., 2001) may in fact show the importance of tight regulation of cerebellar d-serine levels. Moreover, significant d-serine concentrations may occur at localized sites, such as the Bergmann glia (Williams et al., 2006), where there is robust SRR expression, and thereby impact on NMDAR-mediated transmission in the vicinity.
###end p 87
###begin p 88
###xml 206 211 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 202 218 202 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b78">Xia <italic>et al</italic>., 2004</xref>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 290 312 290 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b73">Wolosker <italic>et al</italic>., 1999a</xref>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 386 408 386 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b84">Yoshikawa <italic>et al</italic>., 2006</xref>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 489 516 489 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">Kartvelishvily <italic>et al</italic>., 2006</xref>
###xml 18 21 <span type="species:ncbi:9796">SRR</span>
###xml 72 75 <span type="species:ncbi:9796">SRR</span>
###xml 235 238 <span type="species:ncbi:10116">rat</span>
###xml 249 252 <span type="species:ncbi:10116">rat</span>
###xml 343 346 <span type="species:ncbi:9796">SRR</span>
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
###xml 478 481 <span type="species:ncbi:10116">rat</span>
###xml 557 560 <span type="species:ncbi:9796">SRR</span>
###xml 713 716 <span type="species:ncbi:9796">SRR</span>
###xml 849 852 <span type="species:ncbi:9796">SRR</span>
###xml 954 957 <span type="species:ncbi:9796">SRR</span>
###xml 972 977 <span type="species:ncbi:9606">human</span>
A final aspect of SRR distribution that has remained unclear is whether SRR is expressed by neurons. It has been suggested to be exclusively or principally glial, based on studies in the adult primate (Xia et al., 2004) and developing rat brain and rat neuronal and glial primary cultures (Wolosker et al., 1999a). However, others demonstrate SRR expression in mouse neuronal cultures (Yoshikawa et al., 2006) as well as in cortical neurons of both the developing and the adult rat brain (Kartvelishvily et al., 2006). We did not identify any unequivocally SRR-immunoreactive neurons in the DPFC or hippocampus. This negative result may reflect a species difference, or could reflect a lack of sensitivity of our SRR antibody under the fixation and processing conditions pertaining in the post-mortem tissue. On the other hand, we did find moderate SRR immunostaining of some cerebellar Purkinje neurons, consistent with a minor neuronal contribution to SRR expression in human brain.
###end p 88
###begin title 89
###xml 0 3 <span type="species:ncbi:9925">DAO</span>
###xml 8 11 <span type="species:ncbi:9796">SRR</span>
DAO and SRR expression in schizophrenia
###end title 89
###begin p 90
###xml 165 166 165 166 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 207 208 207 208 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 469 474 469 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 462 481 462 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Kapoor <italic>et al</italic>., 2006</xref>
###xml 626 631 626 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 617 638 617 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">Eastwood <italic>et al</italic>., 2003</xref>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 656 677 656 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">Katsetos <italic>et al</italic>., 1997</xref>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 679 701 679 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">Andreasen <italic>et al</italic>., 1998</xref>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 703 724 703 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">Konarski <italic>et al</italic>., 2005</xref>
###xml 874 877 874 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P =</italic>
###xml 989 994 989 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 982 1001 982 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">Kapoor <italic>et al</italic>. (2006</xref>
###xml 1247 1248 1247 1248 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1470 1471 1470 1471 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1569 1587 1569 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">Cid &amp; Ortega, 1993</xref>
###xml 1589 1614 1589 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">Brockhaus &amp; Deitmer, 2002</xref>
###xml 1616 1636 1616 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">Huang &amp; Bordey, 2004</xref>
###xml 3 6 <span type="species:ncbi:9925">DAO</span>
###xml 130 133 <span type="species:ncbi:9925">DAO</span>
###xml 262 265 <span type="species:ncbi:9925">DAO</span>
###xml 312 315 <span type="species:ncbi:9796">SRR</span>
###xml 435 438 <span type="species:ncbi:9925">DAO</span>
###xml 785 788 <span type="species:ncbi:9925">DAO</span>
###xml 823 826 <span type="species:ncbi:9925">DAO</span>
###xml 925 928 <span type="species:ncbi:9925">DAO</span>
###xml 1032 1035 <span type="species:ncbi:9925">DAO</span>
###xml 1116 1119 <span type="species:ncbi:9925">DAO</span>
###xml 1334 1337 <span type="species:ncbi:9925">DAO</span>
###xml 1342 1345 <span type="species:ncbi:9796">SRR</span>
###xml 1388 1391 <span type="species:ncbi:9796">SRR</span>
###xml 1439 1442 <span type="species:ncbi:9925">DAO</span>
If DAO contributes to NMDAR hypofunction in schizophrenia, then presumably it does so via enhancement (rather than impairment) of DAO function, as this will promote d-serine degradation and thence decreased d-serine occupancy of NMDARs. Our finding of increased DAO mRNA in the cerebellum, without any change in SRR expression, may offer support to this hypothesis, and extends a preliminary study that also found increased cerebellar DAO mRNA in schizophrenia (Kapoor et al., 2006). The findings also support the emerging view that the cerebellum is an integral part of the circuitry affected in schizophrenia (e.g. Eastwood et al., 2003- for reviews see Katsetos et al., 1997; Andreasen et al., 1998; Konarski et al., 2005). However, our data are subject to the caveat that although DAO mRNA was significantly increased, DAO immunoreactivity showed only a trend increase (P = 0.062). Moreover, we did not determine whether DAO activity is elevated. However, it is noteworthy that Kapoor et al. (2006) did find enhanced cerebellar DAO activity in schizophrenia to accompany the mRNA elevation. In this regard, were DAO function increased in schizophrenia the consequences would be difficult to predict, given the uncertain status and function of d-serine in the cerebellum outlined above. One possibility, given our demonstration of DAO and SRR in Bergmann glia and unchanged cerebellar SRR in schizophrenia, is that a putative increased DAO could impact Bergmann glia d-serine levels and thence, speculatively, their regulation of synaptic input to Purkinje neurons (Cid & Ortega, 1993; Brockhaus & Deitmer, 2002; Huang & Bordey, 2004).
###end p 90
###begin p 91
###xml 463 490 463 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">Harrison &amp; Weinberger, 2005</xref>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 492 508 492 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">Law <italic>et al</italic>., 2006</xref>
###xml 946 951 946 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 937 958 937 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Bendikov <italic>et al</italic>., 2007</xref>
###xml 1082 1087 1082 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1078 1094 1078 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">Law <italic>et al</italic>., 2007</xref>
###xml 1154 1155 1154 1155 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1178 1183 1178 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1171 1190 1171 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b80">Yamada <italic>et al</italic>., 2005</xref>
###xml 1556 1559 1556 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P =</italic>
###xml 1822 1827 1810 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1817 1834 1805 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b79">Yagi <italic>et al</italic>., 1956</xref>
###xml 21 24 <span type="species:ncbi:9925">DAO</span>
###xml 94 97 <span type="species:ncbi:9925">DAO</span>
###xml 196 199 <span type="species:ncbi:9925">DAO</span>
###xml 236 239 <span type="species:ncbi:9925">DAO</span>
###xml 600 603 <span type="species:ncbi:9925">DAO</span>
###xml 646 649 <span type="species:ncbi:9925">DAO</span>
###xml 703 706 <span type="species:ncbi:9925">DAO</span>
###xml 856 859 <span type="species:ncbi:9925">DAO</span>
###xml 885 888 <span type="species:ncbi:9925">DAO</span>
###xml 1124 1127 <span type="species:ncbi:9925">DAO</span>
###xml 1223 1226 <span type="species:ncbi:9925">DAO</span>
###xml 1521 1525 <span type="species:ncbi:10116">rats</span>
###xml 1540 1543 <span type="species:ncbi:9925">DAO</span>
###xml 1717 1725 <span type="species:ncbi:9606">patients</span>
###xml 1803 1806 <span type="species:ncbi:9925">DAO</span>
###xml 1939 1942 <span type="species:ncbi:9925">DAO</span>
###xml 1974 1979 <span type="species:ncbi:9606">human</span>
###xml 2003 2006 <span type="species:ncbi:9925">DAO</span>
Increased cerebellar DAO in schizophrenia may arise for one of several reasons. The fact that DAO mRNA is increased indicates that the mechanism is likely to involve transcriptional regulation of DAO expression. This perhaps relates to DAO's candidacy as a putative schizophrenia susceptibility gene, as the associated polymorphisms are all non-coding and so the mechanism of association is probably through an effect on gene expression, as for other risk genes (Harrison & Weinberger, 2005; Law et al., 2006). Our sample size was too small to investigate whether any of the schizophrenia-associated DAO polymorphisms contributed to the elevated DAO expression seen here in the disorder. Regardless, as DAO risk alleles are carried by only a minority of cases and by some control subjects as well, this seems unlikely to explain a diagnostic difference in DAO expression. Moreover, as DAO was not increased in the DPFC (present data and Bendikov et al., 2007) in schizophrenia, one would have to postulate a region-specific effect of genotype which, although not unprecedented (Law et al., 2007), is not parsimonious. Also, DAO genotype does not predict d-serine levels (Yamada et al., 2005). Instead, increased cerebellar DAO in schizophrenia may arise as part of the broader pathophysiological processes, e.g. downstream of other genetic, developmental or environmental influences. One example in the last category is anti-psychotic medication. Although there was no significant effect of haloperidol administration in rats on cerebellar DAO expression (P = 0.428), the means were approximately24% higher in the treated animals, and so it is possible that medication could have contributed to the elevation seen in patients. An early study reported that the antipsychotic drug chlorpromazine inhibits DAO activity (Yagi et al., 1956), but to our knowledge there have been no subsequent investigations of the effects of antipsychotics on DAO expression or activity. Future human post-mortem studies of DAO expression in larger samples with more accurate and extensive medication histories will help to clarify this issue.
###end p 91
###begin p 92
###xml 254 255 254 255 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 484 485 484 485 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 549 554 549 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 542 561 542 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">Foltyn <italic>et al</italic>., 2005</xref>
###xml 649 650 649 650 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 826 849 826 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b66">Strisovsky <italic>et al</italic>., 2005</xref>
###xml 1184 1189 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1178 1196 1178 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Dumin <italic>et al</italic>., 2006</xref>
###xml 0 3 <span type="species:ncbi:9796">SRR</span>
###xml 64 67 <span type="species:ncbi:9925">DAO</span>
###xml 151 154 <span type="species:ncbi:9796">SRR</span>
###xml 511 514 <span type="species:ncbi:9796">SRR</span>
###xml 702 705 <span type="species:ncbi:9925">DAO</span>
###xml 883 886 <span type="species:ncbi:9796">SRR</span>
###xml 908 911 <span type="species:ncbi:9796">SRR</span>
###xml 1040 1043 <span type="species:ncbi:9796">SRR</span>
###xml 1150 1153 <span type="species:ncbi:9796">SRR</span>
SRR immunoreactivity was increased in schizophrenia, but unlike DAO, this occurred in the DPFC not the cerebellum, and was not accompanied by elevated SRR mRNA. The increase was not hypothesized - in that it would suggest increased rather than decreased d-serine levels - and its explanation remains unclear. It may be consequent to other pathophysiological changes; for example, it may reflect an attempted compensatory response to possible disease-associated reductions in cortical d-serine, or that cortical SRR is acting as an eliminase (Foltyn et al., 2005), as noted above. This latter explanation has the attraction of thereby explaining how d-serine is metabolized in the cortex despite absent DAO activity; however, it remains controversial as to whether the eliminase reaction occurs under physiological conditions (Strisovsky et al., 2005). Mechanistically, the fact that SRR was elevated but not SRR mRNA suggests regulation at the translational or post-translational level. One possibility is decreased protein degradation, as SRR protein levels are regulated by ubiquitin-dependent proteasomal degradation, a mechanism modulated by the SRR binding partner Golga3 (Dumin et al., 2006). Whether Golga3 is altered in schizophrenia is unknown.
###end p 92
###begin p 93
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 192 212 192 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b65">Steffek <italic>et al</italic>. (2006</xref>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 502 523 502 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">Bendikov <italic>et al</italic>. (2007</xref>
###xml 651 652 651 652 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 804 805 804 805 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 973 974 973 974 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 67 70 <span type="species:ncbi:9796">SRR</span>
###xml 236 239 <span type="species:ncbi:9796">SRR</span>
###xml 312 315 <span type="species:ncbi:9796">SRR</span>
###xml 539 542 <span type="species:ncbi:9796">SRR</span>
###xml 953 956 <span type="species:ncbi:9796">SRR</span>
Speculation as to the significance and the cause of increased DPFC SRR in schizophrenia should in any event be limited, as variable findings have emerged from two other recent studies. First, Steffek et al. (2006) reported no change in SRR in prefrontal cortex in schizophrenia, although they did find increased SRR in the hippocampus; the different demographics of the subjects studied (theirs were considerably older) may account for the anatomical discrepancy. In contrast, in a third brain series, Bendikov et al. (2007) found reduced SRR in frontal cortex (area 10) and hippocampus. Unlike the other studies, these authors also directly measured d-serine concentrations, overcoming some of the interpretational uncertainty. They replicated the prior reports of reduced cerebrospinal fluid and blood d-serine in schizophrenia, but did not find a reduction in parietal cortex. Overall, therefore, no consensus has yet emerged from the data regarding SRR expression, nor d-serine itself, in the cerebral cortex in schizophrenia.
###end p 93
###begin title 94
Limitations of the study
###end title 94
###begin p 95
###xml 89 96 89 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 147 154 147 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Z</italic>
###xml 705 712 705 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 886 891 886 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 871 898 871 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">Korostishevsky <italic>et al</italic>., 2004</xref>
###xml 1181 1182 1181 1182 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1359 1360 1359 1360 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1434 1435 1434 1435 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1491 1492 1491 1492 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1545 1550 1545 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1535 1557 1535 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">Kumashiro <italic>et al</italic>., 1995</xref>
###xml 1647 1648 1647 1648 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1732 1737 1732 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1722 1744 1722 1744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Hashimoto <italic>et al</italic>., 2003</xref>
###xml 1746 1750 1746 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">2005</xref>
###xml 17 20 <span type="species:ncbi:9925">DAO</span>
###xml 574 577 <span type="species:ncbi:9925">DAO</span>
###xml 936 939 <span type="species:ncbi:9925">DAO</span>
###xml 1275 1278 <span type="species:ncbi:9925">DAO</span>
###xml 1283 1286 <span type="species:ncbi:9796">SRR</span>
Some measures of DAO expression differed between the two cohorts of brains studied here (Table 2), even though the basic demographics are similar (Table 1). The reasons are unknown. However, because the effect of origin of brains had been seen previously we conducted our primary data analyses on Z-scored data, allowing the two series to be combined, generating a larger data set and thence more robust results. Nevertheless, this variability does raise the issue of the general applicability of the findings; inspection of the raw data shows that the increased cerebellar DAO immunoreactivity and mRNA in schizophrenia, whilst seen in both the London and Oxford series, was more apparent in the former (Table 2). Interestingly, expression of G72 (DAOA) in schizophrenia has also shown a cohort effect with a larger change in schizophrenia in one series than the other (Korostishevsky et al., 2004). It is plausible that expression of DAO, and other genes in its regulatory pathway, are particularly susceptible to unknown factors (ranging from genetic variation to peri-mortem confounders) that differ between brain series. The other main limitation of the present study is that d-serine itself was not measured, even though most of the functional implications of altering DAO and SRR expression are implicitly or explicitly the result of their effect upon d-serine levels. In our case, tissue availability precluded measurement of d-serine, and given some reported confounding factors of d-serine measurement in post-mortem tissue (Kumashiro et al., 1995), other studies may also have to use the activity and/or expression of genes involved in d-serine metabolism, or its concentration in blood or cerebrospinal fluid (Hashimoto et al., 2003, 2005) as proxy measures.
###end p 95
###begin title 96
Conclusions
###end title 96
###begin p 97
###xml 152 153 152 153 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 277 278 277 278 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 385 386 385 386 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 94 97 <span type="species:ncbi:9925">DAO</span>
###xml 102 105 <span type="species:ncbi:9796">SRR</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 251 254 <span type="species:ncbi:9925">DAO</span>
###xml 367 370 <span type="species:ncbi:9796">SRR</span>
###xml 470 473 <span type="species:ncbi:9925">DAO</span>
###xml 557 560 <span type="species:ncbi:9925">DAO</span>
This study provides the first detailed description of the regional and cellular expression of DAO and SRR in the human brain. The findings suggest that d-serine synthesis is primarily glial and occurs in the cerebellum as well as the cerebral cortex. DAO expression and thence d-serine catabolism is also glial in the cerebellum, and given the cellular expression of SRR, may regulate d-serine levels at localized sites such as the Bergmann glia. However, in the cortex DAO is neuronal, suggesting a different catabolic route, although the lack of cortical DAO activity, despite robust expression, remains a paradox.
###end p 97
###begin p 98
###xml 170 171 170 171 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 229 249 229 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58">Olney &amp; Farber, 1995</xref>
###xml 251 262 251 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">Coyle, 1996</xref>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 264 281 264 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b69">Tsai <italic>et al</italic>., 1998</xref>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 283 305 283 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">Hashimoto <italic>et al</italic>., 2003</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">2005</xref>
###xml 313 328 313 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">Moghaddam, 2003</xref>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 330 355 330 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">Heresco-Levy <italic>et al</italic>., 2005</xref>
###xml 65 68 <span type="species:ncbi:9796">SRR</span>
###xml 89 92 <span type="species:ncbi:9925">DAO</span>
This study demonstrated increased expression in schizophrenia of SRR in the DPFC, and of DAO in the cerebellum. The results provide some support for theories of aberrant d-serine metabolism and NMDAR dysfunction in the disorder (Olney & Farber, 1995; Coyle, 1996; Tsai et al., 1998; Hashimoto et al., 2003, 2005; Moghaddam, 2003; Heresco-Levy et al., 2005). However any pathophysiological interpretation remains speculative given the various uncertainties and inconsistencies dicussed here.
###end p 98
###begin p 99
This paper is dedicated to Robert Kerwin, who provided some of the tissue studied here, and who made a major contribution to the study of glutamate in schizophrenia. We also thank Margaret Esiri, Brendan McDonald and the MRC Brain Bank at the Institute of Psychiatry, London, for additional tissue provision and for neuropathological evaluations of the material, and Louise Hutchinson for technical assistance. L.V. is a recipient of a Wellcome Trust studentship. Additional support was provided by the Medical Research Council and Stanley Medical Research Institute.
###end p 99
###begin title 100
Abbreviations
###end title 100
###begin p 101
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
d-amino acid oxidase
###end p 101
###begin p 102
dentate gyrus
###end p 102
###begin p 103
dorsolateral prefrontal cortex
###end p 103
###begin p 104
glyceraldehyde-3-phosphate dehydrogenase
###end p 104
###begin p 105
granule cell layer
###end p 105
###begin p 106
grey matter
###end p 106
###begin p 107
molecular layer
###end p 107
###begin p 108
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 9 10 9 10 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
N-methyl-d-aspartate receptor
###end p 108
###begin p 109
phosphate-buffered saline
###end p 109
###begin p 110
PBS-0.3% Triton X-100
###end p 110
###begin p 111
polymerase chain reaction
###end p 111
###begin p 112
Purkinje cell layer
###end p 112
###begin p 113
ribosomal 18s
###end p 113
###begin p 114
Bergmann glia radial processes
###end p 114
###begin p 115
sodium dodecyl sulphate
###end p 115
###begin p 116
serine racemase
###end p 116
###begin p 117
standard saline citrate
###end p 117
###begin p 118
white matter.
###end p 118
###begin title 119
References
###end title 119
###begin article-title 120
'Cognitive dysmetria' as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?
###end article-title 120
###begin article-title 121
###xml 32 33 32 33 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 80 83 <span type="species:ncbi:10116">rat</span>
Ultrastructural localization of d-amino acid oxidase in microperoxisomes of the rat nervous system
###end article-title 121
###begin article-title 122
###xml 36 37 36 37 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia
###end article-title 122
###begin article-title 123
###xml 163 166 <span type="species:ncbi:10116">rat</span>
Elevated striatal dopamine levels following administration of D-DOPA and its alpha-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat
###end article-title 123
###begin article-title 124
###xml 95 98 <span type="species:ncbi:10116">rat</span>
Long-lasting modulation of synaptic input to. Purkinje neurons by Bergmann glia stimulation in rat brain slices
###end article-title 124
###begin article-title 125
###xml 216 219 <span type="species:ncbi:10116">rat</span>
The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat
###end article-title 125
###begin article-title 126
###xml 83 84 83 84 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia
###end article-title 126
###begin article-title 127
Glutamate stimulates [3H]phorbol 12,13-dibutyrate binding in cultured Bergmann glia cells
###end article-title 127
###begin article-title 128
###xml 59 60 59 60 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Evidence for association and epistasis at the DAOA/G30 and d-amino acid oxidase loci in an Irish schizophrenia sample
###end article-title 128
###begin article-title 129
The glutamatergic dysfunction hypothesis for schizophrenia
###end article-title 129
###begin article-title 130
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human serine racemase: moleular cloning, genomic organization and functional analysis
###end article-title 130
###begin article-title 131
G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis
###end article-title 131
###begin article-title 132
###xml 14 15 14 15 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Modulation of d-serine levels via ubiquitin-dependent proteasomal degradation of serine racemase
###end article-title 132
###begin article-title 133
###xml 48 53 <span type="species:ncbi:9606">human</span>
Expression of serotonin 5-HT2A receptors in the human cerebellum and alterations in schizophrenia
###end article-title 133
###begin article-title 134
Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex
###end article-title 134
###begin article-title 135
Cerebellar synaptic protein expression in schizophrenia
###end article-title 135
###begin article-title 136
The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology
###end article-title 136
###begin article-title 137
###xml 40 41 40 41 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Serine racemase modulates intracellular d-serine levels through an alpha,beta-elimination activity
###end article-title 137
###begin article-title 138
###xml 29 30 29 30 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Immunochemical properties of d-amino- acid oxidase
###end article-title 138
###begin article-title 139
Polymorphism in the 5'-promoter region of serine racemase gene in schizophrenia
###end article-title 139
###begin article-title 140
###xml 47 48 47 48 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 64 67 <span type="species:ncbi:10116">rat</span>
Regional distribution and postnatal changes of d-amino acids in rat brain
###end article-title 140
###begin article-title 141
Genes for schizophrenia? Recent findings and their pathophysiological implications
###end article-title 141
###begin article-title 142
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
###end article-title 142
###begin article-title 143
###xml 159 162 <span type="species:ncbi:10116">rat</span>
Effect of the intracerebroventricular and systemic administration of L-serine on the concentrations of D- and L-serine in several brain areas and periphery of rat
###end article-title 143
###begin article-title 144
###xml 26 27 26 27 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
Decreased serum levels of d-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
###end article-title 144
###begin article-title 145
###xml 8 9 8 9 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
###end article-title 145
###begin article-title 146
###xml 65 66 65 66 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 81 82 81 82 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 93 96 <span type="species:ncbi:10116">rat</span>
Anatomical distribution and postnatal changes in endogenous free d-aspartate and d-serine in rat brain and periphery
###end article-title 146
###begin article-title 147
###xml 47 48 47 48 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 63 66 <span type="species:ncbi:10116">rat</span>
Extracellular concentration of endogenous free d-serine in the rat brain as revealed by in vivo microdialysis
###end article-title 147
###begin article-title 148
Distribution and pharmacology of alanine-serine-cysteine transporter 1 (asc-1) in rodent brain
###end article-title 148
###begin article-title 149
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
d-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
###end article-title 149
###begin article-title 150
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 75 78 <span type="species:ncbi:10116">rat</span>
d-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes
###end article-title 150
###begin article-title 151
###xml 16 17 16 17 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 79 82 <span type="species:ncbi:10116">rat</span>
Localization of d-amino acid oxidase in Bergmann glial cells and astrocytes of rat cerebellum
###end article-title 151
###begin article-title 152
Glial glutamate transporters limit spillover activation of presynaptic NMDA receptors and influence synaptic inhibition of Purkinje neurons
###end article-title 152
###begin article-title 153
Effect of the glycine modulatory site of the N-methyl-D- aspartate receptor on synaptic responses in kitten visual cortex
###end article-title 153
###begin article-title 154
###xml 133 136 <span type="species:ncbi:9925">DAO</span>
Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, D-amino acid oxidase (DAO) and kynurenine aminotransferase-1 (KAT-1)
###end article-title 154
###begin article-title 155
###xml 16 17 16 17 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Neuron- derived d-serine release provides a novel means to activate N-methyl-D-aspartate receptors
###end article-title 155
###begin article-title 156
###xml 31 32 31 32 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Immunochemical relationship of d-amino acid oxidases in various tissues and animals
###end article-title 156
###begin article-title 157
Neuropathology of the cerebellum in schizophrenia-An update: 1996 and future directions
###end article-title 157
###begin article-title 158
Structural basis of D-DOPA oxidation by D-amino acid oxidase: alternative pathway for dopamine biosynthesis
###end article-title 158
###begin article-title 159
Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?
###end article-title 159
###begin article-title 160
Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis
###end article-title 160
###begin article-title 161
###xml 5 6 5 6 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Free d-serine in post-mortem brains and spinal cords of individuals with and without neuropsychiatric diseases
###end article-title 161
###begin article-title 162
Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment
###end article-title 162
###begin article-title 163
###xml 90 93 <span type="species:ncbi:10116">rat</span>
Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in rat hippocampus and cortex
###end article-title 163
###begin article-title 164
Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia
###end article-title 164
###begin article-title 165
Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5'-SNPs associated with the disease
###end article-title 165
###begin article-title 166
G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies
###end article-title 166
###begin article-title 167
No association of G72 and d-amino acid oxidase genes with schizophrenia
###end article-title 167
###begin article-title 168
###xml 15 18 <span type="species:ncbi:9925">DAO</span>
Association of DAO with schizophrenia in the Chinese population
###end article-title 168
###begin article-title 169
###xml 90 93 <span type="species:ncbi:10116">rat</span>
High affinity - and - serine transporter Asc-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices
###end article-title 169
###begin article-title 170
Bringing order to the glutamate chaos in schizophrenia
###end article-title 170
###begin article-title 171
###xml 35 36 35 36 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 59 62 <span type="species:ncbi:10116">rat</span>
Immunocytochemical localization of d-amino acid oxidase in rat brain
###end article-title 171
###begin article-title 172
###xml 22 23 22 23 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 39 40 39 40 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 52 53 52 53 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 98 99 98 99 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Determination of free d-aspartic acid, d-serine and d-alanine in the brain of mutant mice lacking d-amino acid oxidase activity
###end article-title 172
###begin article-title 173
A genetic variant of the serine racemase gene is associated with schizophrenia
###end article-title 173
###begin article-title 174
###xml 58 59 58 59 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 64 65 64 65 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 96 99 <span type="species:ncbi:10116">rat</span>
Sodium benzoate differentially blocks circling induced by d-and l-dopa in the hemi-parkinsonian rat
###end article-title 174
###begin article-title 175
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
d-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor
###end article-title 175
###begin article-title 176
###xml 21 22 21 22 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Distribution of free d-serine in vertebrate brains
###end article-title 176
###begin article-title 177
Glutamate receptor dysfunction and schizophrenia
###end article-title 177
###begin article-title 178
###xml 27 28 27 28 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 55 60 <span type="species:ncbi:4932">yeast</span>
###xml 64 70 <span type="species:ncbi:9606">humans</span>
Physiological functions of d-amino acid oxidases: from yeast to humans
###end article-title 178
###begin article-title 179
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
Evidence from gene knockout studies implicates Asc-1 as the primary transporter mediating d-serine reuptake in the mouse CNS
###end article-title 179
###begin article-title 180
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 74 77 <span type="species:ncbi:10116">rat</span>
d-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors
###end article-title 180
###begin article-title 181
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
d-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release
###end article-title 181
###begin article-title 182
###xml 23 24 23 24 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Examination of G72 and d-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder
###end article-title 182
###begin article-title 183
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
d-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices
###end article-title 183
###begin article-title 184
Serine racemase protein expression in cortex and hippocampus in schizophrenia
###end article-title 184
###begin article-title 185
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Dual substrate and reaction specificity in mouse serine racemase: identification of high-affinity dicarboxylate substrate and inhibitors and analysis of the beta-eliminase activity
###end article-title 185
###begin article-title 186
###xml 49 52 <span type="species:ncbi:9796">SRR</span>
No association between the serine racemase gene (SRR) and schizophrenia in a German case-control sample
###end article-title 186
###begin article-title 187
In vivo modulation of N-methyl-D-aspartate receptor-dependent long-term potentiation by the glycine modulatory site
###end article-title 187
###begin article-title 188
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
d-serine added to antipsychotics for the treatment of schizophrenia
###end article-title 188
###begin article-title 189
###xml 54 57 <span type="species:ncbi:9925">DAO</span>
Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction
###end article-title 189
###begin article-title 190
###xml 35 36 35 36 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 66 67 66 67 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Spatiotemporal relationships among d-serine, serine racemase, and d-amino acid oxidase during mouse postnatal development
###end article-title 190
###begin article-title 191
###xml 31 32 31 32 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Immunocytochemical analysis of d-serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neurons
###end article-title 191
###begin article-title 192
###xml 45 46 45 46 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission
###end article-title 192
###begin article-title 193
###xml 68 69 68 69 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Purification of serine racemase: biosynthesis of the neuromodulator d-serine
###end article-title 193
###begin article-title 194
###xml 24 27 <span type="species:ncbi:9925">DAO</span>
Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia
###end article-title 194
###begin article-title 195
Induction of serine racemase by inflammatory stimuli is dependent on AP-1
###end article-title 195
###begin article-title 196
###xml 0 1 0 1 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 40 41 40 41 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 50 51 50 51 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
d-dopa is unidirectionally converted to l-dopa by d-amino acid oxidase, followed by dopa transaminase
###end article-title 196
###begin article-title 197
###xml 39 44 <span type="species:ncbi:9606">human</span>
Characterization and localization of a human serine racemase
###end article-title 197
###begin article-title 198
###xml 56 57 56 57 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Inhibitory action of chlorpromazine on the oxidation of d-amino-acid in the diencephalon part of the brain
###end article-title 198
###begin article-title 199
###xml 120 121 120 121 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 44 47 <span type="species:ncbi:9796">SRR</span>
###xml 87 90 <span type="species:ncbi:9796">SRR</span>
###xml 95 98 <span type="species:ncbi:9925">DAO</span>
Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels
###end article-title 199
###begin article-title 200
###xml 84 85 84 85 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
Contribution of astrocytes to hippocampal long-term potentiation through release of d-serine
###end article-title 200
###begin article-title 201
###xml 65 66 65 66 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 97 100 <span type="species:ncbi:10116">rat</span>
Immunohistochemical evidences for localization and production of d-serine in some neurons in the rat brain
###end article-title 201
###begin article-title 202
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Distribution and MK-801-induced expression of serine racemase mRNA in rat brain by real-time quantitative PCR
###end article-title 202
###begin article-title 203
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Expression of the mRNA and protein of serine racemase in primary cultures of rat neurons
###end article-title 203
###begin article-title 204
###xml 66 69 <span type="species:ncbi:10116">rat</span>
MK-801 upregulates the expression of d-amino acid oxidase mRNA in rat brain
###end article-title 204
###begin article-title 205
Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects
###end article-title 205
###begin article-title 206
###xml 41 42 41 42 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 74 77 <span type="species:ncbi:10116">rat</span>
Cellular and subcellular distribution of d-aspartate oxidase in human and rat brain
###end article-title 206

